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Summary
Traditional Chinese medicine (TCM) has been used in the treatment of a variety of 
diseases and is recognized as a valuable alternative to conventional medicine.
Increasing effort is being made towards scientific proof, clinical evaluation and
molecular study of TCM. To facilitate such an effort, I develop a database which 
contains the available information about all major aspects of TCM, including herbal 
formulations, herbal composition, chemical composition, molecular structure and
functional properties, therapeutic and toxicity effects, clinical indication and
application.
With the rapid development of computer technologies, computational methods
have been widely employed in biology. Support Vector Machine (SVM), based on
statistical learning theory, is such a method that has been used in a wide range of real-
world problems such as text categorization, cancer diagnosis, glaucoma diagnosis, and
microarray gene expression data analysis. In this study, SVM is used to facilitate the 
study of TCM formulae. The results indicate the capability of SVM in recognizing 
non-effective formulae and it may provide some helpful hints for herbalist doctors to 
determine the effectiveness of a TCM formula. In addition, the computation provides 
several potentially effective formulae from the hundreds of randomly mixed formulae. 
It is unclear whether these formulae have the therapeutic value. The method is
expected to facilitate the prescription of new and novel TCM formulae as well as the 
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validation of existing TCM formulae while more and more formulae are under
scientific studies.
The mechanism of action of TCM remains largely unknown, though a large
number of active compounds have been isolated from these herbs and their clinical and 
therapeutic effects have been probed. INVDOCK, a molecular interaction-based
method, is employed to study the molecular mechanism of medicinal herbs. This study 
provides the potential targets of a medicinal herb Serenoa repens in the treatment of 
BPH, parts of which have been demonstrated by previous experiments to be bound by 
compounds in the extract. Besides these interactions, other bindings between particular 
compounds and protein targets have not been proven by experiments. It provides a new 
method for exploration of the mechanism of herb medicine. It is also of importance in 
drug development based on herbs. In conclusion, as a relatively fast-speed and low-
cost tool, this method may find application in systematic study of the molecular
mechanism of multiple ingredients of other medicinal plants and has to be further 
validated by clinical trials.
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Chapter 1:  Introduction
1.1    Brief History of Traditional Chinese Medicine (TCM)
Traditional Chinese Medicine (TCM) has been used for thousands of years [1-5].
At least it has a recorded history dating back over 2,000 years. Among numerous 
legends about the origins of traditional Chinese medicine, stories about three legendary 
emperors/mythical rulers: Fu Xi, Shen Nong and Huang Di have to be mentioned. 
Historians believe that Shen Nong and Fu Xi were early tribal leaders. Fu Xi is
regarded as a cultural hero who developed the trigrams of Yi Jing. Ancient books said 
‘Fu Xi drew the eight trigrams, and created nine needles’. Shen Nong, the legendary 
emperor who lived 5000 years ago, is regarded as the ‘Divine Farmer’ by the Chinese 
people because of his attribution as the founder of herbal medicine. To test and analyze 
the individual effects of different plant medicine, Shen Nong ingested them by himself.
It was said that Shen Nong tested over one hundred herbs including 70 toxic
substances in one day in order to find some drug to get rid of people's pain form 
illness.
Huang Di Nei Jing (Yellow Emperor's Cannon of Internal Medicine) is the first 
written documentation on traditional Chinese medicine, which was written between
800 BC and 200 BC [6]. This book summarized and systematized the previous
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experience of treatment and theories of medicine, such as the meridian theory, as well 
as many other issues, including physiology, pathology, prevention, diagnosis, treatment 
and acupuncture etc. It was regarded as the foundation for the theories of Chinese 
medicine.
During the Zhou dynasty,  the theory of TCM was developing very fast. The most 
important discoveries of medicine were made, including the theoretical foundations of 
Yin and Yang [7], the five elements, the pathogenic factors of external environment as a 
cause of disease and further understanding of the meridians of acupuncture. 
The basic theories of acupuncture were established and stone needles became
obsolete, being replaced by metal needles. At the time of the Spring and Autumn 
Warring States Period, one of the most important issues in the development of TCM 
was the usage of the pulse for diagnosis. Bian Que [8], a very famous doctor/physician 
was the first man in the world to use this technique. He was reputed to be an excellent 
diagnostician, excelled in using acupuncture and moxibustion, boiled herbal
prescriptions, and massage in internal medicine, external medicine, gynaecology, and 
paediatrics for the treatment of all kinds of illnesses. Bian Que also recorded his
experiences in the book Nan Jing (The Classic of Difficult Issues), which developed 
and explained the fundamental and difficult parts of Huang Di Nei Jing.
During this Period another famous classic book Shen Nong Ben Cao Jing (Shen
Nong's Classic of Materia Medica) [9] was written. This book recorded and described
the characters of about 365 herbs and was regarded as the first pharmacopoeia of 
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traditional Chinese herbal medicine.
The Han dynasty, which lasted almost four and a half centuries, was a period of a 
thriving Chinese culture. TCM was well developed as well. Zhang Zhongjing (150-219
A.D.), one of the most famous herbalist doctors, was reputed for his remarkable
medical skill and his well known medical masterpiece Shang Han Lun (Treatise on 
Febrile Diseases) [10], which was used as a standard reference work for traditional 
Chinese medicine, including moxibustion, needling and herbal medicine. So far his
theory and prescriptions are still of great practical value. In this period there also was 
one famous physicians/surgeon of traditional Chinese medicine, Hua Tuo (110-207
A.D). He invented the use of anaesthesia called Ma Fei San [11] to reduce the pain of 
patients who was suffering surgery. He also furthered the knowledge of anatomy. He 
was the first person who used narcotic drug in the world and his skill in this field was 
ahead of the west about 1600-1700 years.
Li Shizhen was considered to be China's greatest scholar in TCM and made great 
contribution to the progress of TCM. He spent forty years to collect and taste herbal 
medicines and wrote down in his most well-known Chinese herbal book Ben Cao
Gang Mu (Herbal Systematics) [12,13], which contained 1892 different herbs (with 
1110 drawings), and was divided into 6 sections, 52 scrolls and 60 different categories 
and also included 11,096 prescriptions, for treating hundreds of illnesses, ranging from 
the common cold to drunkenness and food poisoning. Others such as Wang Shuhe, 
Huang Fumi, Ge Hong, Chao Yuanfang, Sun Simiao and Wang Weiyi also wrote
important medical manuals and contributed to the thriving of TCM.
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Indeed, TCM has a long history, and in what is regarded as a breakthrough, the 
World Health Organization (WHO) in 1979 released a list of 43 types of pathologies, 
which can be effectively treated with acupuncture. Today, there are many hospitals in 
China, Japan, and the other Asia countries that practice TCM exclusively, and others 
that combine Eastern and Western healing methods. One of the main reasons that TCM 
is still used may be their relatively low side effects, compared with western medicine. 
Another reason may be that it is used as a last resort, when Western medicine is too 
toxic or unable to provide the expected benefit [14]. In recent years, the effectiveness 
of TCM has been gaining popularity in US and European countries, such as Germany, 
France and UK [2,15]. However, there are also negative attitude toward TCM. Some 
westerners think that TCM is unscientific in its understanding of the human body and 
the nature of disease and its treatment. They believe that the lack of quality control and 
the absence of scientific and clinical proof of their effectiveness will impede the
adoption of TCMs in industrialized countries [1,16-18].
1.2    Chinese Medicinal Herbs in TCM
As the most important parts of TCM, medicinal herbs and the prescriptions of 
multiple herbs, which will be discussed in the next chapter, were given much attention 
in the development of TCM [4,5]. In TCM, people think that the actions of herbs in 
treatment of diseases is through rectifying the balance of Yin or Yang, and then
consequently helping the body restore its normal physiological functions. Different
herbs have different characters and functions. That is why different herbs are used 
when curing different diseases. To understand the mechanism of them and use them 
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properly, it is necessary to study and explain their characters. Ancient experts had, 
from the TCM viewpoint, summarized those characters, which include drugs'
Properties and Flavors, Meridians of herbs and Toxicity property, etc. Based on the 
theories of Yin and Yang, Viscera, Channels and Collaterals, and treatment principles of 
traditional Chinese medicine, the information has been summed up throughout a long 
history of medical practice.
1.2.1  Properties and Flavors
Each herb has its own properties and flavors. Generally, there are four typical types 
of properties, that is, cold, hot, warm or cool [19]. These properties are experientially
summarized according to the actions of the herbs on the human body. Herbs that cure
or reduce heat syndrome (Yang syndrome) have a cold or cool property, whereas herbs
that cure or reduce cold syndrome (Yin syndrome) have hot or warm property. Cold or 
cool properties are quite different from warm or hot. People think that cold and cool 
are similar, and so are warm and hot. The difference is merely the action abilities. Cold
is relatively ‘stronger’ than cool and hot is ‘stronger’ than warm. Cool- or cold 
-natured herbs are thought to have the effects of clearing heat, purging fire, removing 
toxic substances, and nourishing Yin, so they are usually used to cure heat syndromes. 
On the contrary, warm and hot –natured herbs are believed to have the effects of 
dispersing cold, warming up the interior, supporting Yang, and treating collapse, and 
are therefore used to treat cold syndromes. In addition to the four properties mentioned 




Flavor of herbs is given partly by their tastes. Sometimes they are given according 
to the actions of herbs rather than tastes. Therefore, the flavors of some herbs are often 
different from their true tastes. There are a total of seven flavors, including pungent, 
sweet, sour, bitter, salty, tasteless and astringent [19]. The first five ones are the basic. 
Herbs with different flavors usually show different pharmacological and therapeutic 
actions, while the same flavor comes out the similar effects. According to Yin and Yang
theory, herbs with pungent, sweet or tasteless flavor have the attribution of Yang and 
the ones with sour, bitter or salty flavor, of Yin.  The effects of pungent herbs are to
disperse exopathogens from the body and promote the circulation of the vital energy 
and blood. Therefore, these herbs, such as Herba Ephedrae (Ma Huang), Radix
Aucklandiae (Mu Xiang), are often used in treatment of superficial and mild illnesses.
The effects of sweet herbs are to nourish, replenish, or enrich the function of the 
organs, to normalize the function of the stomach and spleen, to harmonize the
properties of different herbs and to relieve spasm and pain, etc. They are usually 
effective in treating syndromes of deficiency type, dry cough, constipation, such as 
Radix Codonopsis pilosulae (Dang Shen), Radix Rehmanniae Preparata (Shu Di) and 
Radix Glycyrrhizae (Gan Cao). The effects of sour herbs are to induce astringency and 
arrest discharge. They are often used to treat sweating. For example, Fructus
Schisandrae (Wu Wei Zi), a very important adaptogen can be used to regulate body 
functions and increase the organism’s ability to deal with stress. Herbs with bitter 
flavor have the effects of clearing heat, purging fire, sending down the adverse flow of 
Qi to treat cough and vomiting, relaxing the bowels, eliminating dampness, etc. Such 
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herbs are mostly used for syndromes of pathogenic fire, cough with dyspnea, vomiting, 
constipation due to heat of excess type, damp-heat syndrome, or cold-damp syndrome 
and other syndromes. Herbs with salty flavor have the effects of relieving constipation 
by purgation, and softening and resolving hard mass. They are used in the treatment of
dry stool and constipation, scrofula, goiter and mass in the abdomen. Two examples 
are Concha Arcae (Wa Leng Zi) and Natrii Sulfasl (Mang Xiao). The effects of 
tasteless herbs are to excrete dampness and induce diuresis. Therefore these herbs, 
such as Polyporus umbellatus (Zhu Ling) and Poria (Fu Ling), are often used for 
edema and dysuria. Astringent herbs have similar actions as those sour herbs, such as 
Os Draconis (Long Gu), Concha Ostreae (Mu Li) and Halloysitum Rubrum (Chi Shi 
Zhi).
Table 1. Properties and Associated Effects of Herb
Property Effects
Cold Quells fire (anti- inflammatory/spasmodic, sedative).
Cool Subdues heat (reduces fever, detoxifies, lowers BP).
Mild Gentle effects (does not alter Hot or Cold conditions).
Warm Enhances circulation (alleviate chills, improves organ function).
Hot Dispels Cold (breaks Qi blockage, warms the center).
Note: Cool and cold herbs do overlap, as do hot and warm herbs.
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Herbs that possess the same flavors and properties generally have similar effects.
But if only one property or flavor is the same, their actions may be quite different. For 
example,  both Rhizoma Coptidis (Huang Lian)  and Radix Rehmanniae Preparata
(Sheng Di Huang) are cold, however the former is bitter and the latter is sweet. It has 
been well known about the effects of these two herbs. Rhizoma Coptidis has the effects 
of clearing heat and drying dampness and is therefore used for damp-heat syndrome, 
while Radix Rehmanniae Preparata has the effects of clearing heat and nourishing Yin
and is used for the condition of consumption of Yin due to febrile diseases. Table 1 and 
Table 2 give the four typical properties and five typical flavors, respectively, and the 
corresponding effects. 
Table 2. Flavors and Associated Effects of herb
Flavor Effect
Sweet Nourishing, tonifying.
Pungent Dispersing, decongesting, stimulating.
Salty Diuretic, purgative, softening
Sour Astringent, absorbing, circulation.
Bitter Sedating, anti- inflammatory/Fire, soothing.
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1.2.2  Meridians of Herb
According to Viscera, Channels and Collaterals theory, the symptoms can reflect 
the organs that are not in good conditions. So ancient herbalist doctors speculated that 
a herb might selectively act upon a particular part of the body and this part depended 
on the corresponding symptoms that the herb can relieve. These parts of the body are 
named meridians. There are twelve types of merid ians [19], including Lung, Bladder,
Spleen, Large Intestine, Stomach, Small Intestine, Liver, Pericardium, Heart, Kidney,
Gallbladder and San Jiao. The Lung is the most delicate and most exterior of all the 
organs. Diseases often happened because of external pathogenic invasion and
accumulation of Lung heat. The Bladder transforms and excretes fluids from the body. It 
is extremely sensitive to climatic changes, which can cause induced patterns of
Cold-Damp and Damp-Heat. The Spleen is the primary source of nourishment of the 
body because it governs digestion and the production of Qi. It is most susceptible to the 
evil of Dampness. The Large Intestine is used to receive food from the Small Intestine, 
absorb fluids and excrete feces. When excessively exposed to cold, External Cold can 
invade it resulting in abdominal pain and diarrhea. The Stomach has the function to 
digest and transform food to make it available to the Spleen. The state of the Stomach is 
governed by the Hot-Cold nature of ingested food in rela tionship to the patient’s
constitution and the environment. The Small Intestine receives the transformation
products of food and drink from the Stomach and separate the pure from the impure. It is 
also affected by the heat or coldness of ingested food and drink. The liver is the central 
organ of the body, which is primarily responsible for the storage of Blood and the 
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smooth distribution of Qi throughout the body. Exterior Wind can interfere with the 
smooth flow of Qi and stir up the Blood stored in the Liver to exacerbate Internal Liver 
Wind and cause skin rashes of sudden onset that move around the body, often seen in 
viral exanthema, drug rashes and hives. The Pericardium is membranous sac filled with 
serous fluid that encloses the heart and the roots of the aorta and other large blood 
vessels. Disease can be caused by cold, heat and Liver Qi stagnation. The heart controls 
the blood vessels and regulates the flow of blood in the body. The kidney represents 
the most important energetic organ in the body with regard to the root of energy and 
the will to live, develop and reproduce. It is the foundation of Yin and Yang in the body. 
Fear, anxiety, shock and prolonged stress are the major emotional issues that deplete 
Kidney energy. The Gallbladder is used to store and secrete bile. The Excessive 
ingestion of greasy or fatty foods leads to Dampness that becomes lodged in the
Gallbladder. The emotions of anger, repressed resentment and frustration cause Heat 
and Liver and Gallbladder Fire, and when mixed with Dampness, give Damp-heat.
Climatic changes of Heat and Dampness from the exterior will induce elements of 
Damp-Heat in the Gallbladder. San Jiao refers to Shang Jiao, Zhong Jiao and Xia Jiao, 
which are the pathway through which Qi and Jing Ye ascend or descend. Disease can 
be caused by Wind-Damp, Cold-Damp and Heat.
By acting on one or more particular meridians, medicinal herbs can regulate the 
body to a balance status. For example, Fructus Zizyphi Jujubae (Da Zao) can tonify Qi 
in the spleen and stomach. It is indicated for poor appetite and loose stool due to 
weakness of the spleen and stomach. Judged by the above indications and analysis, we 
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say that the herb enters the meridians of the spleen and stomach. Herba Ephedrae (Ma 
Huang) can promote sweating, soothe asthma and benefit urination. It is used for fever, 
chills and absence of sweating due to invasion by exogenous pathogenic wind and cold, 
dysuria, edema and so on. So people believe that the herbs can enter the lung and 
bladder meridians.
The meridian theory studies the physiological function and pathological change on 
the meridians and the related zangfu organs. The essential functions of the meridian 
system are to transport Qi and blood, to maintain conductivity and to resist invasion of 
exogenous pathogenic factors. The meridian system distributes to all parts of the body. 
The endless circulation of Qi and blood in the meridians is responsible for the
maintenance of life and the variety of functions which support it. The meridian theory 
has been the guiding principle for the clinical practice in the realms of TCM,
particularly in those of acupuncture, massage and Qi Gong. By combining the
meridian theory with the theories of the zangfu organs and the etiology of TCM, one 
can thoroughly explain both the physiological activities and pathological changes,
which take place in the body. In this manner, a theoretical basis for the principle of 
treatment in accordance with the differentiation of symptoms and signs was
established.
1.2.3  Toxicity and Nontoxicity
Traditionally, people, especially those in Chinese communities, believed that 
medicinal herbs were weakly toxic or even non-toxic. However, some herbs are toxic 
Chapter 1
12
and should also be used carefully. According the difference of their toxicities, they are 
classified to three classes: toxic, extremely toxic and slightly toxic [19]. Improper use 
of the toxic herbs may lead to adverse effects, so prescription of toxic herbs should be 
careful according to the patient’s age and the situation of the disease, etc. Nontoxic
herbs are moderate in nature and usually do not have any side effects. For example, 
Fructus Zizyphi Jujubae (Da Zao) and Poria (Fu Ling) are nontoxic herbs, while Radix
Aconiti lateralis (Fu Zi) and Semen Strychni (Ma Qian Zi) are toxic. 
Some toxic herbs are effective because of the other effects on the patient, so 
when used in combination of other herbs in a prescription, the toxicities are expected 
to be eliminated or lessened by means of processing, dispensing and preparation. On 
the contrary, the medical effects of some toxic herbs, on the critical or obstinate
diseases, are due directly to their toxicity properties. 
1.3.   TCM Formulae
1.3.1  Compatibility of Herbs
Two or more herbs are often combined in order to increase or promote their
therapeutic effectiveness, to minimize toxicities or side effects, to accommodate
complex clinical situations and to alter their actions. Different combinations can cause 
diverse therapeutic effects. Using only one herb in a formula is called “Single herb 
formula”. The combination of two or more herbs is known as “mutual reinforcement,
mutual assistance, mutual restraint, mutual counteraction, mutual suppression and
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mutual antagonism” [20]. The details for combining herbs are classified as follows.
 1. Single herb formula. The whole formula is composed of only one herb. This 
formula is used when the disease is not very serious. For example, Formula ‘Du Yi Wei 
Wan’, which only contains Radix Lamiophlomidis rotatae (Du Yi Wei), is used in 
treatment of pain caused by traumatic injury, sprain, rheumatism, contusion of muscles, 
joints and loins, fracture, surgical injury and rheumarthritis.
2. Mutual reinforcement. Two or more herbs with similar properties are combined 
to reinforce their therapeutic actions. For example, Radix et Rhizoma Rhei (Da Huang) 
is combined with Natrii Sulfasl (Mang Xiao) to reinforce the function of purging
downward; Gypsum Fibrosum (Shi Gao) and Rhizoma Anemarrhenae (Zhi Mu) are 
used together to clear heat and subdue fire.
3. Mutual assistance. Two or more herbs in which one or more is the principle herb 
and the others play a subsidiary role are combined. For example, Radix Astragali
(Huang Qi) is combined with Poria (Fu Ling) to replenishe Qi, strengthen the spleen 
and promote urination; Gypsum Fibrosum (Shi Gao) is combined with Radix
Achyranthis bidentatae (Niu Xi) to relieve toothache.
4. Mutual restraint. In the formula, the toxicity or side effects of one herb can be 
reduced or eliminated by the addition of another. For example, the toxicity of Rhizoma
Pinelliae (Ban Xia) can be counteracted or restrained by Rhizoma Zingiberis recens
(Sheng Jiang).
5. Mutual counteraction. It means that one herb in the formula can counteract or 
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restrain the other herb’s toxicities and side effects. In fact, mutual restraint and mutual 
counteraction refer to the same effect of herb from two different aspects. The former is 
focused on how to restrain the toxicity of one given herb, while the latter pays
attention to the counteraction effects of one herb on the other.
6. Mutual suppression. In the formula, one of the herbs weakens or suppresses the 
action of the others. For example, Semen Raphani (Lai Fu Zi), combined with Radix
Ginseng (Ren Shen), weakens the function of the latter in replenishing Qi.
7. Mutual antagonism. When two herbs that have no side effects are combined 
together, severe side effects may result. Traditionally, there existed “eighteen
incompatible medicinal herbs” and “nineteen mutual restraining medicinal herbs”.
When two herbs are combined together in one formula, they may give rise to 
interaction with each other. They may be mutual reinforcement, mutual assistance, 
mutual restraint, mutual counteraction, mutual suppression and mutual antagonism. 
For this reason, combination should be carefully considered according to the
conditions of the patient, and their characters and functions. “Mutual reinforcement”
and “mutual assistance” can enhance their effects and therefore should be used as 
much as possible. “Mutual restraint” and “mutual counteraction” can reduce or
eliminate toxicities and side effects of herbs and therefore can be considered when
using poisonous herbs. “Mutual suppression” and “mutual antagonism” can weaken 
efficacy of herbs or make them lose their efficacy or even give rise to toxicities and 
side effects and therefore should be avoided.
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1.3.2  Precautions and Contraindications
The side effects of TCM formula can be reduced by adding one or two herbal 
ingredients. But sometimes it would be harmful to the patients [20]. So the prescription
should be carefully given out according to condition of the patients. Four
contraindications should be noticed as following:
1. Contra-syndromes. Each herb or each class of herbs has its own intended
functions and effects. Diseases or syndromes other than these intended indications are 
contra-syndromes or contraindications. For example, Herba Ephedrae (Ma Huang) is 
used to induce diaphoresis and relieve asthma, and its indications are affection by
exopathogenic wind-cold, anhidrosis due to exterior syndrome of excess type and
cough due to obstruction of the lung Qi, but in case of spontaneous sweating due to 
exterior syndrome of deficiency type or cough due to lung deficiency, its use should be 
prohibited.
2. Incompatibility of herbs. Some herbs cannot be used in combination with
specific herbs. According to the ancient books and literature of TCM, there are
eighteen pairs of incompatible medicinal herbs and nineteen pairs of mutual restraining 
medicinal herbs.
3. Contraindication for pregnancy. Some herbs cannot be used by pregnant patients. 
These herbs are mainly with strong actions or toxicities, especially Fructus Crotonis
(Ba Dou), Semen Pharbitidis (Qian Niu Zi), Herba Cirsii japonici (Da Ji) and Rhizoma
Sparganii (San Leng). The other herbs that are pungent and hot should also be used 
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with caution during pregnancy, such as Semen Persicae (Tao Ren), Flos Carthami
(Hong Hua), Radix et Rhizoma Rhei (Da Huang) and Radix Aconiti lateralis (Fu Zi).
4. Food taboo. Certain types of food may also influence the action of herbs or 
induce unnecessary side effects. In general, it is advisable not to eat raw, cold, greasy, 
strong smelling or spicy food while taking medicine. From the historical medical
literature, Radix Dichroae (Chang Shan) is contraindicated with onion; Radix
Rehmanniae (Di Huang) and Radix Polygoni multiflori (He Shou Wu) are
contraindicated with onion, garlic and turnip; Herba Menthae (Bo He) is
contraindicated with turtle meat; Poria (Fu Ling) is contraindicated with vinegar; and 
Carapax Trionycis (Bie Jia) is contraindicated with three-colored amaranth.
Each herb has its own functions and indications. The herbs should be selected 
according to their properties, flavors, meridians and toxicity properties. For example, 
Herba Ephedrae (Ma Huang) is pungent, slightly bitter and warm. It is used to treat 
fever, chills and absence of sweating due to an invasion of exogenous wind and cold. It 
is contraindicated in deficiency exterior syndrome with the symptoms mentioned
above.
In one formula, the different dosage of each herbal component is prescribed
according to their effects [20]. Generally speaking, the dosage of the principal
component is bigger than the others. When this formula is used for the treatment of 
patients with different conditions, the dosage of these herbs may be changed in
accordance with specific syndrome. In addition, the dosage of those herbs that are very 
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drastic in nature or extremely poisonous should be strictly controlled to prevent
poisoning.
1.4   Methods for Studying TCM
1.4.1  Theory and Practices of TCM
TCM practice is believed to be based on the principle of maintaining the balance of 
the body. Illness or disease always represents a state of imbalance of Yin and Yang. We 
could consider this concept as the need to find the most appropriate and stable chaotic 
state, with a strong attractor. Over time, TCM has elucidated methods of restoring 
balance to the body, thus curing disease. The two important methods are herbal therapy 
and acupuncture. Although various kinds of imbalances can be treated by either 
method, herbal medicine is excellent at tonification, that is, increasing the energy of a 
particular organ, and balancing the energy when there is excess in one part of the body 
and deficiency in another. Of course, in integrated medicine we can also compile
acupuncture and herbal medicines together – acupuncture for the acute problem, and 
herbs to shore up the underlying deficiency that allowed the acute disease to manifest.
Ancient Chinese herbalist doctors have developed their own language and method 
for diagnosis. The diagnosis is not directly associated with a disease, but the
description of a pattern that seems to be preeminent in the whole body, which includes 
Looking, Smelling, Asking, Pulse diagnosis, etc [21]. The Chinese physical exam is 
able to show a predominant pattern of imbalance in the patient, which, in the Chinese
physician’s eyes, is the disease to be treated. Many dissimilar western diagnoses have 
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similar Chinese patterns of disharmony, and many similar Western diagnoses have 
different Chinese patterns of disharmony. In Chinese medicine there have been periods 
in which one theory of harmony and disharmony dominated over another. Thus, during 
one period, the Five Element Theory of disharmony reigned supreme and during 
another period, the Yin-Yang and Eight Principles Theory of disharmony reigned
supreme. In this paradigm of healing, the western diagnosis is unimportant, as we are 
treating the patient ’s explicit response to his or her inner disturbance, which is going to 
be different for each patient according to his or her initial condition.
1.4.2  Modern Experimental Approach and Clinical Trials for Studying TCM
From the point of view of modern medicine, the effects of herbal drugs result from 
the interaction between herbal ingredients and organs of body [2,5]. It is necessary to 
extract these chemicals and then analyze their physiological effects on humans or their 
action on disease. So far, a considerable body of information on the chemical
composition of medicinal herbs, has been found by researchers and institutes,
especially those in China and Japan. Many purified compounds are then studied or 
subjected to be studied in vitro or on animal models [22]. For example, Radix
Glycyrrhizae (Gan Cao) is one of the most extensively studies Chinese herbs [23-28].
The function of Radix Glycyrrhizae is to reinforce the function of the spleen and 
replenish Qi, to remove heat and counteract toxicity, to dispel phlegm and relieve 
cough, to alleviate spasmodic pain, and to moderate drug actions. It is used in
treatment of weakness of the spleen and the stomach marked by lassitude and
weakness, cardiac palpitation and shortness of breath, cough with much phlegm,
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spasmodic pain in the epigastrium, abdomen and limbs, carbuncles and sores. It is 
often used for reducing the toxic or drastic actions of other drugs. Its main ingredients 
are Glycyrrhizin and glycyrrhetinic acid [25,26]. Experiments show that its extract 
exerts a detoxifying effect [26,27]. Another experiment shows that glycyrrhizin also 
has this effect [26,27]. In addition, Glycyrrhizin has anti- inflammatory effect similar to 
hydrocortisone [28]. It was found that its decoction can inhibit intestinal smooth
muscles of rabbits in vitro, but glycyrrhizin and glycyrrhetinic acid have no such
effects [29]. Thus the effects must be due to the other compounds. Radix Ginseng (Ren 
Shen) being under exploration [30,31], contains more than 200 compounds. The main 
ingredients are ginsenosides, essential oils and polyacetylenes [30]. Radix Ginseng
traditionally has been used as a tonic and was thought to reinforce the vital energy, to 
remedy collapse and restore the normal pulse, to benefit the spleen and lung, to
promote the production of body fluid, and to calm the nerves. Experiments have shown 
that Radix Ginseng can act on the central nervous system and exert significant
cardiotonic and hypertensive effects on acute circulatory failure cardiotonic and
hypertensive effects on acute circulatory failure after heavy blood loss and decrease 
the level of blood sugar and promote phagocytosis and enhancing
lymphocyte-blastogenesis rate [29]. These effects are related to the active compounds. 
For example, ginsenoside Rg1 can raise blood pressure, while Rb1 can lower it
[31,32].
As indicated in the above examples, chemical and biological studies underlined the 
importance of using both together in the standardization and modernization of TCM. 
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The chemical profiles of an extract should be matched against the results of biological 
assays in order to assure lot-to-lot consistency of what are fairly crude extracts of herbs 
with high natural variability [1]. Chemical analysis, biological assays and animal
experiments provide important fundamental information about TCM. In the context of 
modern biomedical research, they should also be necessary prerequisites for clinical 
trials. Most of these TCM clinical trials have been undertaken in China, Taiwan, and 
Japan. A number of commercial treatments based on TCM such as ‘Hu Xin Dan”,
“Puerarin injection’, ‘Shen Mai injection’ and others have been introduced into the 
market after extensive pharmacological research and clinical trials [33,34].
1.4.3  Computational Methods
Conventional approaches, including chemical standardization, biological assays, 
animal models and clinical trials, have been extensively used to study the effects and 
molecular mechanism of medicinal herbs and formulae. More recently, as useful tools, 
computer-aided methods are rapidly developed to facilitate the understanding of TCM. 
To control and evaluate the quality of medicinal herbs, the fingerprint analysis
technique is set up with the rapid development of instrument analyses and computer 
pattern interpretation, which includes fuzzy information analysis, artificial neural
networks and gray relational grade cluster [35-37]. To identify similar medicinal herbs, 
computer-aided classification based on back propagation algorithm of artificial neural 
network pattern recognition is developed [38]. 
Employing a fuzzy clustering method, Su Weiwei et al divided the herbs in one 
formula into several different parts [39-41]. The results agreed well with the
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explanation by TCM theories. Moreover, it provided a feasible computer-aided method 
to study the formulation of prescription. Aiming at this problem, in this study, we 
proposed a new method based on Support Vector Machine (SVM) as discussed in 
Chapter 3 to evaluate the effectiveness of a formula and to generate new potential 
formulae.
To understand the molecular mechanism and pharmacology of bioactive
compounds from Chinese medicinal herbs, which is important in facilitating scientific 
evaluation of novel therapeutic approaches in traditional Chinese medicine, a newly
developed computer software INVDOCK [42] is used for automated identification of 
potential therapeutic and toxicity targets of bioactive compounds isolated from
Chinese medicinal herbs. This method may potentially be used as a relatively
fast-speed and low-cost tool for facilitating the study of molecular mechanism and 
pharmacology of bioactive compounds from Chinese medicinal herbs. And it is also of 
significance in new drug development based on the mechanism of Chinese medicine.
1.5 Specific Aims of the Project
1.5.1  To Develop a TCM Database
Due to the difficulties in accessing and understanding non-English medicinal
records, most scientists are not familiar with traditional Chinese medicine [1].
Moreover, because the TCM theory is very different from that of western medicine, 
majority of these scientists show little interest in TCM and other traditional medicines. 
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To attract their attention and help them better understand the merits of TCM, it is 
necessary to provide the information of TCM first. Hence, a new database, Traditional 
Chinese Medicine Information Database (TCMID), is developed, to provide, in an
integrated manner, comprehensive information about all aspects of TCM, including 
prescription formulae, constituent herbs, known herbal ingredients and their molecular 
actions. The therapeutic effects, adverse reactions, clinical indications and applications 
are provided at the levels of prescription, individual herb and herbal ingredient
respectively. Traditional terminologies about medicinal herbs such as properties,
flavors, sites of actions, toxicity level, and therapeutic class are also given.
1.5.2  To Develop a Computer-aided Method for Prescription Formulation
In recent years, a great deal of pharmacological research has been undertaken to 
review and establish reliable composite formulae of TCM [1]. To facilitate such a study, 
an alternative approach is introduced, based on a computer method, support vector 
machines (SVM), which is a machine learning algorithm currently considered to be 
one of the most efficient method in many real-world applications [43]. Recently SVM
have been applied to a number of biological problems [44], including gene expression 
data analysis and protein classification, etc. Using this method, it is expected to find 
the principle of prescription formulation and then to evaluate the effectiveness of a 
given formula and even generate new formulae.
1.5.3  To Explore the Molecular Mechanism of Medicinal Herb
The mechanism of action of TCM remains largely unknown, though plenty of 
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active compounds have been isolated from these herbs and clinical and therapeutic 
effects are found. This study is proposed to explore the mechanism by a
computer-aided method, INVDOCK. In this study, I analyzed the mechanism of
Serenoa repens, which is widely used in treatment of BPH [45-49]. Although the effect 
of some active compounds extracted from it has been proven by in vivo or in vitro
experiments, the whole picture is still unknown. The multiple ingredients make the 
process more difficult. Hopefully, the effects of the predicted therapeutic and toxicity 
targets will provide us clues of the molecular mechanism of this herb. 
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Chapter 2:  TCM Database Development
2.1    Introduction
Traditional Chinese medicine (TCM) has been used in the treatment of a variety of 
diseases and is recognized as a valuable alternative to conventional medicine
[1,2,16,50]. A major therapeutic approach of TCM is the use of a mixture of herbs, 
each composed of a number of constituent chemicals, which collectively exert
therapeutic actions and modulation of other factors. One or more principal constituents 
provide main therapeutic actions. Certain secondary principal constituents enhance or 
assist the effect of the principle ones. The rest serves modulation roles such as
treatment of accompanying symptoms, moderation of harshness and toxicity,
enhancement of drug delivery, and harmonization etc [1].
Because of growing interest in TCM therapeutics, increasing effort has been made 
towards scientific proof, clinical evaluation and molecular study of TCM [1,2,42].
Such an effort can be facilitated by making available information about all major 
aspects of TCM including herbal formulations, herbal composition, chemical
composition, molecular structure and functional properties, therapeutic and toxicity
effects, clinical indication and application. A few specialized databases have appeared 
which provide information about different aspects of TCM. For instance, The TCMD 
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provides information about Chinese medicinal plants and constituent chemicals [51],
The Chinese Medicine Sampler (http://www.chinesemedicinesampler.com/) and
Traditional Chinese Medicine
(http://www.healthy.net/CLINIC/therapy/Chinmed/Index.asp) databases provide
general information about the history, theory, diagnostics, and examples of TCM
formulae.
However, there is a lack of a database that provides comprehensive information 
about all major aspects of TCM. Moreover, in the existing databases, information
about the composition of constituent chemical compounds in TCM herbs is not
included. A new database, Traditional Chinese Medicine Information Database TCMID, 
is introduced to provide, in an integrated manner, comprehensive information about all 
aspects of TCM including prescription formulae, constituent herbs, known herbal
ingredients and their molecular actions. The therapeutic effects, adverse reactions,
clinical indications and applications are provided at the levels of prescription,
individual herb and herbal ingredient respectively. Traditional terminologies about
medicinal herbs such as tastes, flavors, sites of actions, toxicity level, and therapeutic 
class are also given.
2.2    Database Development Method
In this work, Oracle 9i is selected as the platform for our database projects and data 
future analyzing tasks. Oracle 9i is a typical database management software, which has
the most variety of modules and development tools, including modules for data mining 
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and online analytical process, which is essential for high-end data analysis purpose.
For many years, it leads the way in indexing and query optimization technology while
it is not worse than its competitors in other aspects. Also, Oracle 9i is a fully
object-oriented database, which conforms to the world trend toward object, oriented
programming (OOP). Oracle has kept the biggest market share for years. According to 
2002 statistics (http://www.oracle.com/tellmemore/?1333278), over half of the fortune 
100 corporations use Oracle as their database server.
Oracle 9i is based on a relational approach, which means that database developer 
can create a set of tables (also known as relations) to reflect the inter-relationship
between the data stored in the database. The relational approach needs the support of a
relational database management system (RDBMS). The RDBMS enables users to
create and maintain a relational database. They are designed to control data redundancy,
to restrict unauthorized access, to provide persistent storage for program objects and 
data structures, to permit inference and actions using rules, to provide multiple user 
interfaces, to representing complex relationships among data, to enforce integrity
constraints, and to provide backup and recovery.
2.3 Database Structure and Access
2.3.1 Database and Source of Data
TCMID is freely accessible at http://xin.cz3.nus.edu.sg/group/tcmid/tcmid.asp. The
information collected in TCMID is from a search of available literature [29,52-62].
Efforts are made to collect as many of these known formulae, herbs, herbal
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constituents and compositions, and other functional information as possible. Intensive 
research into TCM and TCM herbal constituents are leading to the discovery of new 
knowledge about different aspects of TCM. It is hoped that new or existing
information missing in this database can be gathered by users’ submission to a special 
page in the database as well as by conducting up-dated literature search.
The database currently contains entries for 1343 formulae, 1325 medicinal herbs, 
4468 herbal ingredients and description about molecular actions of 502 herbal
ingredients. Each entry can be retrieved via the name, alternative name, function or 
clinical manifestation at the levels of prescription formula, herb and herbal ingredient 
respectively. This database will be continually updated as new data are found. And the 
friendly interface will be upgraded as well to meet the user’s needs adequately.
2.3.2 Database Access
The TCMID database web interface is shown in Figure 1. Users can easily search 
the database from three starting points, namely, Formula, Herb and Compound.
‘Formula’ starting point generates a new interface through which the database can be 
accessed by keyword search such as Formula Chinese Names, Formula English Names, 
Formula Functions, Formula Clinical Manifestations, etc. ‘Herb’ starting point
generates another interface to access the herbal information through keyword search 
such as Herb Latin Names, Herb Chinese Names, Herbal Functions, Herbal Clinical 
Manifestations, etc. ‘Compound’ starting point generates the third interface to access 
the chemical information through keyword search such as Compound Name, CAS No, 
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etc. Searches involving any combination of these search or selection fields are also 
supported.
Figure 1. The query interface of TCMID
The full text search is case insensitive and wildcards supported. In a query, a user 
can specify full name or any part of the name in a text field. Wild character of ‘%’ and
‘_‘ is allowed in text field. Here, ‘_’ represents any one character and ‘%’ represents a 
string of characters of any length. For example, input of ‘Ma Huang’ in the Formula
Chinese Name field finds entries containing ‘Ma Huang’ in their name, such as Ma
Huang Tang or She Gan Ma Huang Tang. On the other hand, input of ‘Ma% Tang’
finds all the entries with ‘Ma’ and ‘Tang’ in their names, such as Ma Huang Tang.
The typical query results are illustrated in Figure 2, 3 and 4. Figure 2 gives 
details about the formula, including Chinese Name, Common Name, Literature
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Reference, Herbal Components, Function, Clinical Manifestation, Procedure,
Description, Usage and Dosage, Storage, Precaution and Modifications. From this
page, the herbal information can be obtained by clicking each individual herbal
component.
TCMID Test Result (Formulae Info)
Chinese NameGe Jie Ding Chuan Wan
Common
Name Gejie Dingchuan Pills, Asthma-Relieving Bolus of Gecko
Herbal
Components
Gecko: 11 g; Semen Trichosanthis: 50 g; Radix Asteris : 75 g; 
Herba Ephedrae: 45 g; Carapax Trionycis : (processed with 
Vinegar) 50 g; Radix Scutellariae: 50 g; Radix Glycyrrhizae:
50 g; Radix Ophiopogonis: 50 g; Rhizoma Coptidis : 30 g; 
Bulbus Lilli: 75 g; Fructus Perillae: (stir-fried) 25 g; Gypsum
Fibrosum: 25 g; Semen Armeniacae Amarum: (stir-fried) 50 g; 
Gypsum Fibrosum: (calcined) 25 g.
Procedure
Pulverize the above fourteen ingredients to fine powder, 
sift and mix well. To each 100 g of the powder add 70-100
g of refined honey to make small honeyed pills or big 
honeyed pills.
Description Blackish-brown small honeyed pills or big honeyed pills. 
Odour,slight;taste,bitter and sweet.
Function To nourish yin and cool lung, relieving cough and asthma.
Clinical
Manifestations
Chronic cough of consumptive disease, asthma in the 
aged, short breathing, fever, fullness of chest, perspiration, 
night sweat, anorexia.
Usage & Dose9 g of small honeyed pills or 1 big honeyed pill, 2 times a 
day.
Storage Preserve in tightly closed containers.
Specification 9 g per 60 small honeyed pills, 9 g per big honeyed pill.


















Chinese Asafetida is the resin of Ferula sinkiangensi K. M. Shen or Ferula 
fukanensis K. M. Shen (Fam. Umbelliferae). The stem is incised from the 
upper part to the lower part at the flowering and early fruiting stages in the 
end of spring and early summer. The exuding emulsive resin is collected, 
and dried in the shade.
Description
Irregular lumps or resinous substance. Colour varying in intensity, externally 
waxy-yellow to brownish-yellow. Lumps light, texture waxy; fracture
somewhat pored; freshly cut surface pale, gradually darken on storage. 
Resinous substance viscid, greyish-white. odour, strongly and lastingly 
characteristic and alliaceous; taste, pungent, with the burning sensation on 
chewing.
Function To remove food stagnancy. To disintegrate masses. To kill worms.
Indication To relieve symptoms of stagnation of undigested meat, mass in the









alpha-pinene, beta-caryophy, lene, beta-eudesmol, beta-myrcene,
beta-pinene, camphene, delta(3)-carene, gamma-terpinene, limonene,
myrcene, p-cymene

















Sensory irritation receptor; Increased
androstenedione 16alpha-hydroxylase








Induction of cytochrome P450s CYP2E1,
CYP2C11, CYP2C6 and CYP6B7; Induction of 
cytochrome b5 mRNAs
Figure 4. The typical query result about compound
Figure 3 gives the details about the herb, including Chinese Name, Latin Name, 
English Name, Plant Source, Properties and Flavors, Meridians, Toxicity, Chemical 
Ingredients, Therapeutic Class, Therapeutic Sub-Class, Function, Indications, Clinical 
Manifestations, Collection, Processing, Description, Usage and Dosage, Storage and 
Literature Reference. The chemical ingredient can link to the corresponding page
containing detail chemical information. They include Chemical Name, CAS No,
molecular weight, molecular formula, downloadable structure file and so on (Figure 4).
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2.4 Data Submission and Updating
This database is to be updated quarterly, information regarding newly searched 
TCM formulae, herbs and compounds and additional knowledge them will be added. 
To facilitate submission of new information concerning TCM by other users, a data 
submission interface is included in the database (Figure 5). Submitted information will 
be integrated into the database after validation.
Figure 5. The data submission interface
2.5 Preliminary Analysis of Database
This database currently contains 1343 entries of formulae, 1325 entries of herbs
found from the literature along with 4468 entries of compounds which are extracted
from the herbs. Among these entries of formulae, 1190 entries are relatively complete. 
Their herbal components, functions, clinical manifestations are collected into the
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database. However, the others lack one or more detail features, at least the information 
are not found by now. 
According to their therapeutic effects, the formulae are classified into 17 Classes, 
including formulae to release the exterior, purgative formulae, mediation formulae,
formulae for clearing heat, formulae to dispel cold, tonic formulae, astringent formulae,
formulae for tranquilizing the mind, formulae to promote resuscitation, Qi formulae,
blood formulae, formulae for treating wind, formulae for treating dryness, formulae for 
dispelling dampness, formulae to expel phlegm, digestive formulae, and formulae for 
dispelling parasitic worms. For example, formula Xin Jia Xiang Ru Yin is used to treat 
exterior syndromes due to invasion by summer-heat, dampness and cold. It was
classified under ‘formula to release the exterior’ in the database.
Among these entries of herbs, 1090 entries are relatively complete. Their functions, 
clinical manifestations are collected into the database. One or more detail features 
should be added to the other entries when updating. 
According to their therapeutic effects, the herbs are classified into 23 Classes, 
including anaesthesia, anthelmintic, antitumor, astriction, bleeding control, blood
activation and stasis removal, food digestion, for calming liver and containing wind,
for dissolving dampness by flavors, for dissolving phlegm, stopping cough, and
soothing breathing, for dispelling wind-dampness, for eliminating toxic materials,
dissolving rottenness and growing new muscles, for promoting diuresis and
penetrating dampness, for relieving exterior syndrome, for tonifying weakness, for
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warming interior, heat clearance, mind opening, purging, regulation of Qi, spirit
calming, toxication reduction, anthelmintic, dampness removal, and itching control,
and vomiting promotion. In addition, each class is divided into several sub-classes.
These classifications will facilitate the researchers in collecting and comparing the 
herbs which have the similar effects. For example, Semen Lablab album (Bai Bian Dou) 
is used in treatment of weakness of the spleen and stomach with loss of appetite and 
loose bowels, excessive leukorrhea, vomiting, diarrhea, distress in the chest and
distension in the abdomen caused by summer-damp. In the database, it belongs to the 
Class ‘for tonifying weakness’ and the sub-class ‘for tonifying Qi’.
After further investigation, we found that some herb entries are the same as or very 
similar with the other ones. For example, the database contains ‘Ba Yue Zha’ and ‘Yu
Zhi Zi’. These are two different Chinese name of the same herb. A link is provided in 
each entry to that of the same herb under different name. Thus, user can get sufficient
information about the herb even if he only knows one name of this herb. Most of the 
compounds have the downloadable structure files, which can facilitate the studies of 
compound-biomolecule interactions and drug design.
2.6    Conclusion and Further Development
TCMID is developed from available information about formulae, herbs and
ingredients of herbs in the literature and books, which is a result of collective and 
persistent effort over the years. It provides a new platform to facilitate mechanistic 
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study and clinical evaluation of TCM. In contrast to traditional literature and books, 
the database has the following advantages: reduced data redundancy, data consistency, 
easier use of data and less storage for larger information. In addition, new information 
can be easily incorporated or the corresponding new databases can be cross-linked to 
TCMID to provide more details about TCM.
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Chapter 3:  Development of a Computer-aided
Method for TCM Prescription
Formulation
3.1    Introduction
3.1.1  The Principle of TCM Prescription Formulation
A formula of TCM is composed of one or more Chinese medicinal herbs. It is not a 
simple arbitrary mixture, but a carefully assembled combination of herbal components 
[1,2,16,50]. Each component in a formula has its particular functions. Moreover, they 
are mixed together in proper amounts in accordance with specific principles for
combining herbs. When giving a prescription, herbalist doctor must take into account 
the characters of each herbal component in the formula, as well as the stage of the 
disease and the condition of the patient. According to the different functions of these 
ingredients, they are classified to four categories [15], in order of importance, Jun,
Chen, Zuo, Shi.
Jun (King) are one or two herbal ingredients that give the formula its basic
characteristic actions. They may not be the greatest percentage of the formula, but the 
most important clinical herbal components. They play the leading role in the treatment 
Chapter 3
37
of the disease. Chen (Minister) are the ingredients that strengthen the Jun’s action
aiming at the principle symptoms. They enhance, augment or broaden the effect of the 
Jun. They also play important role in relieving the secondary symptoms. Zuo
(Assistant) are these parts that have different effects in different formula. Firstly, they 
can help the Jun and Chen components in their activities and can also address
secondary symptoms, especially the less important symptoms. Secondly, they will
counteract or attenuate any side effects of the first two combinations. Thirdly, they will 
modify the energy of the formula closer to neutral, when more potential Jun and Chen
components are used in treatment of serious diseases. Shi (ambassador) are these parts 
enable all of the components to be well absorbed, transported and then reach the right 
place where they will take effects, such as liver, heart and stomach. They may also be 
used as a dispensing agent or give flavor or texture.
The components in a formula are in close cooperation with one another when
exerting their due effects. Theoretically the formulae that have proven effective are 
precisely formulated in accordance with their definite aim in treatment the disease. For 
example, Ma Huang Tang (Decoction of Ephedra), which is composed of Herba
Ephedrae (Ma Huang) (9g), Ramulus Cinnamomi (Gui zhi) (6g), Semen Armeniacae
amarum (Ku Xing Ren) (9g), Radix Glycyrrhizae Preparata (Zhi Gan Cao) (6g), has 
the main function to promote sweating and release the exterior. In this condition, the 
lung is invaded by cold; so it is necessary to use herbs with pungent flavor and warm 
property to expel pathogenic factors from the lung. Therefore, Herba Ephedrae is used 
as the Jun ingredient to induce perspiration for dispelling pathogenic wind and cold 
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from the body and to relieve asthmatic cough by ventilating the lung and smoothing 
the flow of vital energy; Gui zhi is the Chen ingredient that aids Herba Ephedrae in 
diaphoresis, warms the channels and stimulates menstrual discharge, reinforces yang, 
relieves palpitation, and promotes the descending of Qi; Semen Armeniacae amarum
serves as the Zuo ingredient to relieve cough and asthma by ventilating the lung, and to 
relax bowels ; and Radix Glycyrrhizae Preparata serves as the Shi ingredient to
harmonize the action of all the other ingredients and direct them to their proper
channels, to reinforce Qi and promote blood circulation. Each formula must contain a 
Jun ingredient. However, some formulae may lack one or more of the other categories. 
For example, Ren Shen Tang (Decoction of Ginseng) has only one ingredient: Radix 
Ginseng (Ren Shen). Its function is to reinforce the vital energy, to remedy collapse 
and restore the normal pulse, to benefit the spleen and lung, to promote the production 
of body fluid, and to calm the nerves. In some formulae, the Jun or Chen ingredient 
may also serve as the Zuo or Shi ingredient. To prescribe an effective formula, the 
doctor should have good understanding of the characters of hundreds of herbs.
3.1.2  Modification of TCM Prescription
The composition of a formula is not static. Patients suffering from the same disease 
may be given different variations of the same formula. Even the same person, during 
different disease stage, is given modified formula. Factors such as the disease
condition, the constitution and age of the patient, the season, and the geographical 
environment should be considered when composing a formula [20]. A very famous 
Chapter 3
39
doctor of Qing Dynasty, Xu Lingtai, said in his book [63] that “before trying to use any 
old handed-down formula, you must first determine whether all the symptoms and 
signs of the patient you are treating are consistent with those described in that
prescription and whether every ingredient is good for the case. If not you must make 
the proper modifications or, if it is impossible to do so, choose another one.” From
what he said, we can see that the formula components are sometimes modified. The 
Jun ingredient must remain the same in the modified formula, but other ingredients are 
added or deleted according to the signs and symptoms present and the stage of the 
disease. For example, Formula Ke Xue Fang has the effects of clearing fire and
resolving phlegmand. But if the condition is associated with severe deficiency of Yin
and blood, Radix Ophiopogonis (Mai Men Dong), Radix Glehniae (Sha Shen) and 
Radix Trichosanthis (Tian Hua Fen) should be added. If the condition is associated 
with severe cough, Radix Asteris (Zi Wan), Flos Farfarae (Kuan Dong Hua) and
Semen Armeniacae (Xing Ren) should be added. If the condition is associated with 
Cough with profuse blood, Bai Bu should be added. Another example is Formula Huo
Xiang Zheng Qi San, which is to release the exterior and resolve dampness. If the 
condition is associated with Indigestion, Massa Fermentata medicinalis (Shen Qu) and
Semen Raphani (Lai Fu Zi) should be added. While if the condition is no chill, fever or 
headache, Radix Angelicae dahuricae (Bai Zhi) and Folium Perillae (Zi Su Ye) should 
be deleted. The examples show that it is not always necessary to follow the set formula. 
On the contrary, proper variations should be made. Similarly, it is not hard to
understand that their relative amounts are also varied according to the patient’s
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condition. Prescriptions consisting of the same substances in different proportions may 
have different effects. Besides, different forms of the same prescription may have 
different level of intensities or actions. The major forms of the prescriptions include 
decoctions, powders, pills, capsules, and honey boluses. Usually in bolus form, the 
action is slow. But when a decoction of the same ingredients is used instead, the action 
becomes quicker [20]. Therefore the decoction form is more appropriate than the bolus 
in serious or critical conditions. 
3.1.3  Previous Studies on Prescription Formulation
In TCM, prescriptions, which are composed of various herbs according to the
principles, are often considered as the major means of treating diseases. Since ancient 
times, TCM physicians have summarized their experiences in this field. Many
effective prescriptions have thus been tested and documented. However, people were 
disappointed to find that there was no direct and reliable approach to prescribe new 
formula toward particular disease. What they can do and are doing is to try to modify 
and improve the existed formulae. Moreover, how the formula may be modified is also 
depended on their special experiences and the constitution of the patients. Fortunately, 
scientists have made progress in developing alternative approach to facilitate the study 
of the formulation of new prescription. Employing a fuzzy clustering method, Su
Weiwei et al divided the herbs in one formula into several different parts according to 
their characters [39-41]. These characters were quantified to generate the feature
vectors that can be recognized by computer. From the first chapter, we notice that 
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different herbs have different characters and functions. That is why different herbs are 
used for treatment of different diseases. To understand the mechanism of herbs and use 
them properly, it is necessary to explore their characters. Ancient experts have, from 
the TCM viewpoint, summarized those basic characters, which include drugs'
Properties and Flavors, Meridians  and Toxicity, etc. Based on the theories of Yin and 
Yang, Viscera, Channels and Collaterals, treatment principles of traditional Chinese 
medicine have been developed and summed up throughout a long history of medical 
practice. From the ancient Chinese medicine books, we can also find that the herbs 
with similar characters have similar effects, while those with different characters have 
quite different effects. In Su’s studies [40,41], they analyze several formulae that have 
proven effective, including Wan Shi Niu Huang Qing Xin Wan, Xiao Chai Hu Tang, 
Hua Tuo Zai Zhao Wan and Nao De Sheng Pian. The results show that the
classification is in accordance with the traditional explanation of Chinese medicine. 
3.2   A New Computer-aided Method for Prescription Formulation
Su’s studies, introduce in the previous chapter, provide us with a method through 
which the characters of herbs can be quantified. We have noticed that a TCM
prescription is a selective combination of multiple herbs, which indicates the
probability of building the quantified characters of the prescription as a whole,
according to those of the herbal components. Based on this analysis, we employ
Support Vector Machine (SVM), a machine learning method, for the first time, to 
explore the principle of prescription formulation, to evaluate the effectiveness of a 
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formula and even generate new formulae. 
3.2.1 Support Vector Machine  (SVM)
SVM is one kind of learning machine based on statistical learning theory. The 
basic idea of applying SVM to pattern classification is as follows: First, the input 
vectors are mapped into a feature space, either linearly or non- linearly, which is
relevant with the selection of the kernel function. And then a hyperplane of the vectors 
in the feature space is constructed which separates two classes (this can be extended to 
multi-class). SVM training always seeks a global optimized solution and avoids
over-fitting, so it has the ability to deal with a large number of features. A complete 
description to the theory of SVMs for pattern recognition is in Vapnik’s book [43].
SVMs have been employed in a wide range of real-world problems such as text 
categorization [64-66], hand-written digit recognition [67,68], tone recognition [69-71],
image classification and object detection [72-77], sub-storm and flood stage
forecasting [78,79], cancer diagnosis [80-83], glaucoma diagnosis [84], microarray
gene expression data analysis [85-87]. It has been shown that SVM is consistently 
superior to other supervised learning methods [88,89].
When used for classification, SVMs separate a given known set of {+1, -1} labeled 
training data via a hyperplane that is maximally distant from the positive samples and 
negative samples (known as Optimal Separating Hyperplane, OSH), then ‘plot’ the test 
data at the high dimensional space, distinguish whether it belongs to positive or
negative according to the OSH. Figure 6 illustrates this process. The solid lines show
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two possible hyperplanes, each of which correctly separates the training data into two
classes. The two dashed lines parallel to the separating hyperplane show the
boundaries in which one can move the separating hyperplane without misclassification. 
We call the distance between each parallel dashed lines as margin.
              Small Margin                Large Margin
Figure 6. Two possible separating hyperplanes
For most of real-world problems, seemingly not to be linearly separable, SVMs can 
handle non- linear hypotheses with any Kernel function, which automatically realizes a 
nonlinear mapping onto a feature space. The optimal separating hyperplane found by 
the SVM in feature space corresponds to a nonlinear decision boundary in the input 
space.
3.2.2 Linear Classification
Let the training data of two separable classes with n samples be represented by
,,,2,1),,(,),,(),,( 2211 niyxyxyx nn "G"GG =  where Ni Rx ∈G  is an N dimensional space, 
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and }1,1{ +−∈iy   is the class index. Given a weight vector w
G
 and bias b  (Figure 
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where Tnwwww ),,,( 21 "G =  is a vector of n elements. Inequalities (1), (2) can be 
combined into a single inequality:
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Figure 7. Definition of Hyperplane and Margin. The circular dots and square dots 















As shown in Figure 8, there exist a number of hyperplanes for each group of 
training data. The classification objective of SVM is to determine an optimal weight 
0w
G
 and an optimal bias 0b  such that the selected hyperplane separates the training 
data with maximum margin. The hyperplane determined by 0w
G
 and 0b  is called 
optimal separation hyperplane (OSH) which is illustrated in Figure 9.
The equation of any given hyperplane can be written as:
0=+• bxw i
T GG                                 (4)
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The OSH can be found by maximizing the above distance or by minimizing the norm 
of w
G
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where 0≥iα are Lagrange multipliers. The solution of this optimization
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By substituting Eq.(8) and (9) into Eq.(7), the QP problem becomes
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i yα  and .,,2,1,0 nii "=≥α
The points situated at the two optimal margins have non-zero coefficients iα
among the solutions to Eq.(10), and are called Support Vectors (SV). The bias 0b  can
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After determination of support vectors and bias, the decision function that













αα            (12)
3.2.3 Nonlinear Classification
As real-world problems are usually nonlinear, the following approach has been
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introduced into SVM to deal with these problems. The original training data x
G
 in the 
input space X is projected into a high-dimensional feature space F via a Mercer kernel 
operator K [67], and the OSH is constructed in this feature space. Such a procedure is 
illustrated in Figure 10.
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The Kernel represents a legitimate inner product in input space:
)()(),( yxyxK T
GGGG φφ •= (15)
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Figure 10. Illustration of basic principle of support vector machines: Step 1: 
project the training data nonlinearly into a higher-dimensional feature space via φ .
Step 2: construct a hyperplane to separate positive and negative datasets with 
maximum margin there.
A number of candidate kernel functions have been used in SVM, including
Polynomial dyxyxK )1(),(
GGGG
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3.3    Dataset Preparation
In this study, 644 TCM formulae (from TCMID database, Chapter 2) are used to 
test the feasibility of this method. Based on the number of herbs in a formula, these 
formulae are classified to 7 groups, from Group 1 to Group 7, in which the number of 
herbs is 4, 5, 6, 7, 8, 9 and 10, respectively. These formulae are used as positive 
samples. 1000 negative samples, which contain the same number of herbs with the 
positive samples in the same group, are randomly generated. These negative samples 
are supposed to be therapeutically noneffective because they are only randomly
compiled complexes of multiple herbs. The total numbers of samples in each group are 
given in Table 3. Both positive and negative formulae in each group are further
randomly divided into two parts with even number of entries, respectively (If the 
number of the positive formulae is an odd number (2n+1), they are divided into two 
parts with n and n+1 formulae, respectively.). One part is used as the training set, 
while the other as the testing set. Thus, from Group 1 to Group 7, the training sets 
contain 42, 41, 46, 42, 50, 47 and 55 positive samples, respectively and 500 negative 
samples which are randomly selected. The testing sets contain 42, 40, 46, 42, 50, 46 
and 55 positive samples, respectively and 500 negative samples.
3.4 Feature Vectors
Construction of feature vectors is one of the key steps in successful SVM
classification.  Because a formula is composed of several different herbs, at first we 
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must construct the vectors of each herb, and then, construct the feature vectors of the 
formula according to some rules that can compile the vectors of all herbs. In this study, 
the feature vectors are simply the concatenation of the vectors of all herbs. I will 
explain it in the following paragraphs.


















Group 1 4 42 42 500 500
Group 2 5 41 40 500 500
Group 3 6 46 46 500 500
Group 4 7 42 42 500 500
Group 5 8 50 50 500 500
Group 6 9 47 46 500 500
Group 7 10 55 55 500 500
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Table 4. Principle for constructing the feature vector
Elements Characters Value
1 Cold 1 (Cold), 1.2 (Extremely cold), or 0.8 (Slightly cold) *
2 Hot 1 (Hot) or 1.2 (Extremely hot) *
3 Warm 1 (Warm), 1.2 (Extremely warm) or 0.8 (Slightly warm) 
*
4 Cool 1 (Cool) or 0.8 (Slightly cool) *
5 Pungent 1 (Pungent) or 0.8 (Slightly Pungent)
6 Sweet 1 (Sweet) or 0.8 (Slightly Sweet) **
7 Sour 1 (Sour) or 0.8 (Slightly Sour) ***
8 Bitter 1 (Bitter) or 0.8 (Slightly Bitter)
9 Salty 1 (Salty) or 0.8 (Slightly Salty)
10 Toxic 1 (Toxic), 1.2 (Extremely Toxic), or 0.8 (Slightly Toxic)
11 Lung 1 (if has)
12 Bladder 1 (if has)
13 Spleen 1 (if has)
14 Large Intestine 1 (if has)
15 Stomach 1 (if has)
16 Small Intestine 1 (if has)
17 Liver 1 (if has)
18 Pericardium 1 (if has)
19 Heart 1 (if has)
20 Kidney 1 (if has)
21 Gallbladder 1 (if has)
22 San Jiao 1 (if has)
* If the herb has mild property, the value of each element should be added 0.25.
** If the herb has tasteless flavor, the value of this element should be added 0.5
*** If the herb has astringent flavor, the value of this element should be added 0.5.
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Since the characters of a herb are essential to its effects, the feature vectors should 
be constructed according to these characters. The characters are quantified and then the 
values of them are used to compose the feature vector. The vector contains 22 elements, 
which are the quantified basic characters of herbal properties, flavors, toxicity property
and meridians that the herb can enter. Table 4. gives probable value for each element of 
the feature vector and also the reason for the choice of the value.
As we have known from previous chapters, each herb has its own properties and 
flavors. There are four typical types of properties, that is, cold, hot, warm or cool.
These four characters are used as four elements of feature vector. If the herb has one of 
these properties, a value ‘1’ is assigned to the element. Otherwise, a value ‘0’ is
assigned to this element. The choice of value ‘1’ is to simplify the construction of the 
vector.
There is also another property: mild. If the herb has this property, the value of the 
elements, which represent Cold, Hot, Warm and Cool, add a value 0.25. It is because 
this property does not belong to any of these four typical ones. The value 0.25 is 
chosen mainly according to our experiences. So are the other values, which are chosen 
to describe the elements in the following paragraphs. The discussion of the choice of 
the value is given in Chapter 3.6. Some herbs are extremely cold and some extremely 
hot, the value ‘1.2’ is assigned to the elements, which represent cold and hot,
respectively. To those herbs with minor cold, minor warm or minor cool, a value ‘0.8’
is assigned to the corresponding element. 
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14 Large Intestine 0
15 Stomach 0






22 San Jiao 0
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There are five major types of herbal flavors, including pungent, sweet, sour, bitter 
and salty.  These characters are also used as elements of the feature vector. If the herb 
has one of these flavors, a value ‘1’ is assigned to this element. If the flavor is minor 
pungent, minor sweet, minor sour, minor bitter or minor salty, a value ‘0.8’ is assigned
to the corresponding element. There are also another two different flavors: tasteless 
and astringent. For tasteless, a value ‘0.5’ is added to the element ‘sweet’ and for 
astringent, to ‘sour’. According to Viscera, Channels and Collaterals theory, the
symptoms can reflect the organs that are not in good conditions. So ancient Chinese
herbalist doctors speculated that a given herb may selectively act upon a particular part 
of the body and this part depends on the corresponding symptoms that the herb can 
relieve. So the vector should also reflect the properties of meridians that herbs affect. 
There are a total of 12 meridians, including Lung, Bladder, Spleen, Large Intestine,
Stomach, Small Intestine, Liver, Pericardium, Heart, Kidney, Gallbladder and San Jiao. 
The quantified characters of these meridians are also used as elements of the feature 
vector. If one herb can enter a meridian, then a value ‘1’ is assigned to the element that 
represents for the meridian. ‘0’ is assigned to the other elements, which are not related 
with this herb. Table 5. gives the feature vector of Herba Ephedrae (Ma Huang), a 
useful herb which has warm properties, pungent and slightly bitter flavors, and can 
enter Lung and Bladder meridians. The related information can be found in TCMID 
database. So does the information of the other herbs, on which the feature vectors are 
built.
After building the feature vector of each herb in a formula, we can construct that of 
Chapter 3
56
the formula. In this study, I connect the elements of all herbs’ vector together to
generate a bigger vector. For example, the formula, which contains 4 herbs, has the 
feature vector with 88 elements, while the vector of a formula (contains 5 herbs) has 
110 elements. Because of the difference of feature vector, we separated the formulae 
into 7 groups and tested them individually (Table 3).
3.5 Accuracy Measure
Accuracy of the results from discriminative methods is commonly measured by the 
quantity of True Positives (TP), True Negatives (TN), False Positives (FP), and False 
Negatives (FN) [91,92]. In addition to these quantities, standard sensitivity, specificity 









are also useful in assessing the prediction accuracy [93]. To estimate performance, we used 
three objective indices: accuracy, specificity and sensitivity. The sensitivity as defined
above is the probability of correctly predicting a positive example. The specificity as 
defined above is the probability of correctly predicting a negative example. All these 
quantities are used in the evaluation of SVM classification of formulae in this work.
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3.6 Results and Discussion
The SVM program can automatically rearrange the training and testing sets.
During the training process, the program can calculate the minimum number of the 
positive samples or negative samples in the training set, which is necessary to reach an 
optimal training result. If the number of the positive samples or negative samples in
the training set is higher than the minimum, the rest samples are automatically
transferred to the testing set. On the contrary, if the number is lower than the minimum, 
some samples in the testing set are taken into the training set and then re-start the 
training process until an optimal training result is achieved. Tables 6 to12 give the 
training and testing sets of positive formulae of each groups after the optimal training 
results are achieved and Table 13 summarizes the number of positive and negative 
samples in the training set and testing set of each group after the training process. The 
results show that the number of the positive samples in the training sets of these groups 
increase (see Table 3). This is perhaps because the numbers of positive samples in the 
original training set is not enough to cover sufficiently diverse range of positive
samples. So a number of positive samples in initial testing set are put into the training 
set. On the other hand, except Group 1, in the other six groups, the number of the 
negative samples in the training set decrease from 500 to a certain number between 
210 and 290. The decrease of the number of negative samples in the training set
indicates that they are enough to achieve the optimal result.
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Table 6. List of Positive Formulae in the Training and Testing Set of Group 1
List of positive formulae (contain 4 herbs)
Training Set
Bai Tou Weng Tang
Bao Chi San
Bei Xie Fen Qing Yin
Bing Lang Chen Qi Tang
Bing Peng San
Cai Shi Tui Re Tang
Cang Er Zi San
Da Cheng Qi Tang
Da Jian Zhong Tang
Da Xian Xiong Wan
Dao Chi San
Ding Xiang Shi Di Tang
Ding Zhi Wan
Fu Zi Xie Xin Tang
Gan Cao Gan Jiang Ling
Zhu Tang
Gan Mao Tui Re Chong Ji
Gan Mao Tui Re Ke Li
Gui Zhi Gan Cao Long Gu 
Mu Li Tan
Gun Tan Wan
He Zi Pi San
Hong Yao Tie Gao
Huai Hua San
Huang Lian Jiang Tang San
Huang Lian Jie Du Tang
Huang Qin Tang
Huang Teng Nan Chang
Tang
Huo Xue Tong Mai Pian
Ji Jiao Li Huang Wan




Ling Gui Zhu Gan Tang
Lou Xing Chen Qi Tang
Ma Huang Tang
Ma Huang Xing Ren Yi Yi 
Gan Cao Tang
Ma Xin Shi Wei Tang
Ma Xing Gan Shi Tang
Meng Shi Gun Tan Wan
Mu Fang Ji Tang




Re Yan Ning Ke Li
San Ao Tang
San Liang Ban Yao Jiu
San Ye Tang
Shen Fu Tang
Sheng Ma Ge Gen Tang
Sheng Ma Huang Qi Tang
Shi Zao Tang
Si Jun Zi Tang
Si Miao Yong An Tang
Si Ni San
Si Sheng Wan
Si Wei Huang Qi Xuan Fu 
Pian
Si Wei Tu Mu Xiang San
Si Wu Tang
Tao Hua San
Tong Xie Yao Fang
Wei Jing Tang
Wu Long Jian Ji
Wu Zhu Yu Tang
Xi Jiao Di Haung Tang
Xiang Su San




Xuan Bai Cheng Qi Tang
Yang Xue Run Chang Jian
Yi Nian Jin
Yu Quan Wan




Fu Ling Gui Zhi Bai Zhu
Gan Cao Tang
Ge Gen Huang Qin Huang
Lian Tang
Ge Gen Qin Lian Pian
Ge Gen Qin Lian Wei Wan
Li Zhong Wan
Ling Gui Zhu Gan Tang
Ma Xing Shi Gan Tang
Ge Gen Huang Lian Tang
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Table 7. List of Positive Formulae in the Training and Testing Set of Group 2




Bai Hu Jia Gui Zhi Tang
Ban Xia Hou Po Tang
Bao Long Wan
Bi Xie Fen Qing Yin
Bu Shen Qiang Shen Pian
Da Huang Mu Dan Tang
Dan Qi Tang
Dang Gui Zhi Tong Tang
Fu Kang Ning Pian
Fu Tu Dan
Fu Zheng Gu Ben Fang
Fu Zi Da Huang Tang
Fu Zi Li Zhong Wan
Gua Lou Qu Mai Wan
Guan Xin Su He Wan
Gui Zhi Fu Ling Wan
Gui Zhi Fu Zi Tang
Gui Zhi Tang
Hou Po Sheng Jiang Ban 
Xia Gan Cao Ren Shen
Tang
Huan Xin Dan
Huang Lian E Jiao Tang
Huang Long Tang
Jian Gu Tang
Jian Xin Fu Mai Lin
Jing Zhi Guan Xin Pian
Ju Yuan Jian
Kui Yang Pian
Ling Bao Hu Xin Dan
Ma Xin Long Xie Xiong 
Tang
Nao De Sheng Pian
Niao Shi 1 Hao
Ning Sou Lu
Qing Hao Bie Jia Tang
Qing Hou Yan He Ji
Qing Nao Jiang Ya Tang
Qing Wei San
Qing Xuan Wan
Qing Yi 1 Hao
Qu Tao Tang
Run Chang Tang
Sang Xin Shi Gao Tang
Shen Xue Pian
Sheng Bai Chong Ji
Shi Qu Gan Ce Da Zao 
Tang
Si Fo He Ji
Suan Zao Ren Tang
Tai Yi Gao
Tao Ren Cheng Qi Tang
Tian Jin Gan Mao Pian
Tian Jin Zhi Ke Tang Jiang







Xin Jia Xiang Ru Yin
Yi Huang San
Yi Huang Tang




Zeng Ye Cheng Qi Tang
Zhen Jiang Gao Yao
Zhen Wu Tang
Zhi Ke Pi Pa Chong Ji
Zhu Ling Tang
Zhu Sha An Shen Wan
Huo Xue Chu Xuan Tang
Testing Set
Tao He Cheng Qi Tang
Bai Hu Jia Ren Shen Tang
Bao Yuan Tang
Fu Fang Da Qing Ye He Ji
Gui Zhi Jia Gui Tang
Ling Gan Wu Wei Jiang
Xin Tang
Huang Qi Gui Zhi Wu Wu
Tang
Kang Bai Huo He Ji
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Table 8. List of Positive Formulae in the Training and Testing Set of Group 3
List of positive formulae (contain 6 herbs)
Training Set
An Shen Ding Zhi Wan
Ban Xia Lu
Bei Mu Gua Lou San
Bing Lang Si Xiao Wan
Bu Fei E Jiao Tang
Chan Su Ding
Chuan Xiong Zhi Tong Tang
Da Bu Yin Wan
De Sheng Wan
Er Cha Er Huang San
Er Chen Tang
Er Zhu Ling Pi Tang
Fei Lian Fen Qing Tang
Fu Fang Gan Yan Chong Ji
Gou Teng Yin
Gu Jing Wan
Guan Xin 2 Hao Yao
Gui Fu Yi Lin Tang
Hua Ban Tang
Hua Shui Zhong Zi Tang
Huo Xue Zhi Tong San
Ji Chuan Jian
Jia Liu Wan
Jia Wei Jiao Hong Yin
Jia Wei Si Ni San
Jiang Can Er Huang San
Zuo Gui Yin
Jie Gu Gao
Jie Re He Ji
Jin Ji Chong Ji
Jin Pu Tang
Jin Suo Gu Jing Wan
Jin Yin Tang
Ku Shen Tong Lin Tang
Lai Zhi San
Lian Mei An Hui Tang
Liang Di Tang
Ling Yang Gan Mao Pian
Liu Shen Wan
Liu Wei Di Huang Wan
Ma Pu San
Ma Ren Run Chang Wan
Mai Men Dong Tang
Nao Ling Su Pian
Ping Wei San
Qi Shu Hua Fen Tang
Qin Lian Pian
Qing Gong Tang
Qing Ying Jie Yu Tang
Ru Kuai Xiao Pian
Run Chang Wan
San Cai Feng Sui Dan
Shan Zha Hua Zhi Wan
Shen Zhu San
Sheng Hua Tang
Sheng Yi Xuan Hua Tang
Si Jun Zi Wan
Si Shen Wan
Suo Pi Yin
Tao Hong Si Wu Tang
Tou Nong San
Tuo Hua Jian
Wan Shi Niu Huang Qing Xin 
Wan
Wu Mei Chen Qi Tang
Wu Tou Gui Zhi Tang
Wu Wei Xiao Du Yin
Xi Huang Wan
Xiao Er Xiao Shi Pian
Xiao Huo Luo Dan
Xiao Jian Zhong Tang
Xiao Tong Tang
Xu Shi Tong Jing Fang
Xuan Jiang Tang
Yi Guan Jian
Yi Mu Cao Gao
Yi Qi Ju Xian Tang
Yi Yi Zhu Ye San
Yin Chai Chong Ji
Yin Qiao Tang
Yue Bi Jia Shu Tang
Testing set
Ai Hu Cheng Qi Tang
Bai Mai An Shen Yin
Fang Ji Huang Qi Tang
Feng Re He Ji
Fu Ling Pi Tang
Gui Fu Li Zhong Wan
Huo Luo Dan
Dang Gui Shao Yao San 
Jia Wei Fu Xie Ning
Jia Wei Wu Yao Tang




Table 9. List of Positive Formulae in the Training and Testing Set of Group 4
List of positive formulae (contain 7 herbs)
Training Set
Ba Zhen Yi Mu Wan
Ban Long Wan
Ban Xia Xie Xin Tang
Bao He Wan
Bu Fei Shen Ji Tang
Bu Yang Huan Wu Tang
Cai Hu Qing Gan Yin
Chai Hu Shu Gan San
Chong Cao Bu Tian Jing
Da Qing Long Tang
Da Yuan Yin
Dang Gui Liu Huang Tang
Dang Gui Si Ni Tang
Di Yu Wan
Fei Er Wan
Fu Fang Chan Yi Yin
Fu Fang Lei Gong Teng
Jian Ji
Gan Cao Xie Xin Tang
Gan Ji San
Ge Gen Tang








Jia Jian Dang Gui Si Ni
Tang
Jia Wei Gui Zhi Fu Ling
Wan
Jia Wei Zhi Zhuo Gu Ben
Tang
Jiang Ya Ping Pian
Jie Biao Tui Re Fang
Jin Lian Mao Gong Yin
Ku Shen Tang
Lan Di Tang
Li Pi Su Fei Tang
Lian Po Yin
Liu Yi Bing Zhu San Ma
You Hu
Luo Han Guo Zhi Ke Chong 
Ji
Ma Zi Ren Wan
Mi Zhen Tang
Mu Li Ze Xie San
Qi Bao Mei Ran Ke Li
Qi Wei Du Qi Wan
Qi Wei Pu Tao San
Qi Wei Zhi Shen Tang
Qian Bai Bi Yan Pian
Qiang Huo Sheng Shi Tang
Qin Lian Si Wu Tang
Qing Li Tang
Qu Feng Zhi Tong Pian
Shan Zha Xiao Mi Tang
Shang Dong E Jiao Gao
She Xiang Zhen Tong Gao
She Yang Tang
Shen Jin Dan Jiao Nang
Sheng Ge Er Chong Tang
Shun Jing Tang
Tian Tai Wu Yao San
Tiao Gan Tang
Wan Ying Gao
Wei Kang Ling Jiao Nang
Xiao Chai Hu Tang
Xiao Er Yi Niao Fang
Xiao Yao Wan
Xing Jun San
Xuan Fu Dai Zhe Tang
Yang He Tang
Yang Wei Li Qi Tang
Yi Qi Huo Xue Pian
Yu Zhen San
Yun Qi San
Zhen Xin An Shen Tang
Zhi Sou San
Zhi Zhi Tang
Zhu Ye Mai Dong Shi Gao 
Tang
Zhu Ye Shi Gao Tang
Sha Shen Mai Dong Tang
Testing Set
Dang Gui Si Ni Tang Dang Gui Jian Zhong Tang Huang Qi Jian Zhong Tang
Huo Bu San Ren Tang Ji Xue Teng Gao
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Table 10. List of Positive Formulae in the Training and Testing Set of Group 5
List of positive formulae (contain 8 herbs)
Training Set
Ba Wei Qing Xin Chen Xiang 
San
Ba Wei Tan Xiang San
Ba Zhen Wan
Ban Xia Bai Zhu Tian Ma
Tang
Bei Ling San
Bi Xue Shen Shi Tang
Bu Dai Wan
Bu Zhong Yi Qi Wan
Chan Su Wan
Chuan Bei Qing Fei Tang
Jiang
Chuan Xiong Cha Tiao Wan
Er Long Zuo Ci Wan
Fu Yuan Huo Xue Tang
He Che Da Zao Wan
Hua Yu Qing San Tang
Hui Tian Zai Zao Wan
Huo Xue Run Zao Sheng Jin 
San
Jia Jian Tuo Hua Jian
Jia Jian Wei Rui Tang
Jia Wei Ban Xia Hou Po Tang
Jia Wei Fu Zi Li Zhong Tang
Jia Wei Xiao Yao San
Jian Wei Cha
Jiao Ai Tang
Jie Nue Qi Bao Yin
Kuo Qing Yin
Li Gan Long Pian
Li Ling Tang
Ling Yi Bai Jiang Tang
Mi Niao Xi Jie Shi Fang
Nu Bao
Qi Gong Tang
Qi Guan Yan Wai Tie Fang
Qi Ju Di Huang Wan
Qi Li San
Qi Shao Ji Cao Tang
Qiang Xin Ying
Qing Gan He Jie Tang
Qing Gu San
Qing Guo Wan
Qing Lin He Ji
Quan Long Si Zi Tang
Ren Shen Ding Chuan Tang
Rou Gan Xi Feng Tong Luo 
Tang
Ru Xiang Ding Tong Wan
San Bai Tang




Shen Kang Ning Pian
Shen Qi Wan
Shu Gan Chong Ji
Ku Shen Zhi Yang Tang
Si Chong Huo Xue Tang
Snag Piao Xiao San
Su Wei Tang
Su Xiao Niu Huang Wan
Tan Du Jian
Tong Jing Zhi Ke Tang
Tong You Tang
Tuo Li Ding Tong Tang
Wen Dan Tang
Wu Cao Tang
Wu Jia Qiang Xin Tang
Xian Qi Yin
Xiang Sha Liu Jun Zi Wan
Xiao Ban Tang




Yang Yin Li Yan Tang
Yang Yin Qing Fei Tang
Yi Chan He Ji
You Gui Yin
Zao Du Fu Jiang Tang
Zhen Xin Di Tan Tang
Zhi Shi Dao Zhi Wan
Zhi Shu He Wei Tang
Zhi Xue Tang
Zuo Gui Wan
Kang Bao Kou Fu Ye
Kai Xiong Shun Qi Wan
Testing Set
Da Bu Yuan Jian
Da Chai Hu Tang
E Jiao Yi Shou Jing
Er Dong Tang
Er Yin Jian
Fu Fang Yi Bai He Ji
Gou Zai Hua He Ji
Hou Po Wen Zhong Tang
Huang Qi Gui Di Tang
Jia Wei Wu Pi Yin
Jin Gui Shen Qi Wan
Juan Bi Tang
Mai Wei Di Huang Wan
Niu Huang Jie Du Pian




Table 11. List of Positive Formulae in the Training and Testing Set of Group 6
List of positive formulae (contain 9 herbs)
Training Set
Ai Fu Nuan Gong Wan
An Kun Zan Yu Wan
Ba Zhen San









Gui Ling Gan Lu San
Gui Ling Ji
Gui Zhi Shao Yao Zhi Mu 
Tang
Hu Qian Wan
Huang Qi Yi Shen Tang
Huang Qi Zhu Fu Tang
Jia Jian Yi Qi Gu Chong
Tang
Jia Kang Ping Wan
Jia Wei Xiao Yao Wan
Jian Pi Ding Xian Tang
Jiao Mei Bing Guan Tang
Jin Fei Cao San
Jing Zhui Fang
Jiu Wei Qiang Huo Keli
Jiu Wei Qiang Huo Tang
Jiu Wei Qiang Huo Wan
Jiu Wei Zi Shen Wan
Ju Fang Zhi Bao San
Jun Li Tang
Kai Wei Qi Cao
Kang Gu Zeng Sheng Wan
Kang Yuan Tang
Li Shi Hua Yu Tang
Liang Ge San
Ling Yang Qing Fei San
Lu Jin Yin
Mu Dan Pi Tang
Niu Bang Jie Ji Tang
Pai Shi Chong Ji
Qi Long Tang
Qi Zhen Wan
Qing Li An Shen Tang
Qing Qi Hua Tan Wan
Qing Xin Lian Zi Yin
Qing Yan Wan
Qing Ying Tang
Qing Zao Jiu Fei Tang
Ren Shen Bai Du San
Ren Shen Zi Bu Gao
Ru Mi Niao Tang
Sha Mai Yu Tian Tang
Shao Fu Zhu Yu Tang
Shao Yao Tang
She Gan Ma Huang Tang
Shen Jiang Xie Xin Tang
Sheng Li Pian
Si Ling He Qin Shao Tang
Ti Qi Yi Zhong Tang
Tiao Wei He Ji
Ting Tao Chen Qi Tang
Tong Qiao Huo Xue Tang
Wei Hu Tang
Wei Qi Shuang Jie Tang
Wei Yan Yan Fang
Wen Yang Tong Mai Tang
Wu Shao She Yin
Xi Ling Jie Du Pian
Xiao Er Jin Dan Pian
Xiao Tan Hua Jie Tang
Xiao Ying Tang
Xie Fei Tiao Zhong Fang
Xuan Bi Tang
Xuan Fei Zhi Ke Tang
Xue Xie Gua Lou Tang
Yang Xue Dang Gui Jing
Yi Jia Jian Zheng Qi San
Yi Qi Yang Yin Tang
Yin Qiao Jie Du Wan
Yu Yin Zhi Beng Tang
Zhi Gan Cao Tang
Zhi Shi Xiao Pi Wan
Zhi Zhuo Gu Ben Wan
Zhu Shi Tang
Zhu Ye He Ji
Zi Shen Rong Jing Wan
Zi Yin Xuan Fei Tang
Jiu Xian San
Testing set
Jia Jian Bu Zhong Yi Qi
Tang
Jiu Wei Xiao Ding Yin
Ding Chuan Tang
Ma Xin Qin Ting Tang
Man Gan Jiu Wei Tang
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Table 12. List of Positive Formulae in the Training and Testing Set of Group 7
List of positive formulae (contain 10 herbs)
Training Set
An Nao Niu Huang Pian
An Shen Bu Xin Wan
Bai He Gu Jin Wan
Bao Gu Jiu
Bu Gan Yi Qi Tang
Bu Shen Yi Nao Tang
Can Shi Tang
Da Huang Qing Wei Wan
Da Huo Luo Wan
Dan Dao Pai Shi Er Hao
Fang
Dan Zhi Xiao Yan San
Fang Nian Lian Tang
Fu Fang Zang Lian Wan
Fu Gan Tang
Gan Lu Yin
Gan Wei Bai He Tang
Gong Ti Wan
Gu Chong Tang
Han Lian Cao Jian
Hou Zheng Wan
Hu Gu Yao Jiu
Hu Po Bao Long Wan
Hua Yu Zhi Beng Tang
Hui Yan Zhu Yu Tang
Huo Xiang Zheng Qi Kou Fu 
Ye
Huo Xiang Zheng Qi Shui
Huo Xue Tong Luo Tang
Ji Sheng Shen Qi Wan
Ji Xue Teng Tang
Jia Jian Xiao Cai Hu Tang
Jia Wei Bai He Di Huang Tang
Jia Wei Xiang Su San
Jian Nao An Shen Tang
Jie Du Huo Xue Tang
Jie Xiao Tang
Kui Yang He Ji
Lan Wei Xiao Yan Pian
Li Dan Pai Shi Pian
Lian Kui Yu Yang Tang
Ling Jiao Gou Teng Tang
Lu Shang Yu Zhen
Lu Tai Gao
Mi Yuan Jian
Mie Di Ku Shen Tang
Mie Di Tang
Mu Xiang Shun Qi Wan
Niu Huang Bao Long Wan
Qing Fei Yi Huo Wan
Qing Fei Yin Zi
Qing Gan An Tai Yin
Qing Shi Yi Qi Tang
Qu Feng Zheng Rong Tang
Re Du Qing
San Huang Shi Gao Tang
Shang Gan Tang
Shao Fu Zhu Yu Wan
Shen Lu Bu Gao
Shen Rong Jiu
Shi Hu Si Jin Tang
Shi Quan Da Bu Gao
Shi Quan Da Bu Wan
Shi Wei San
Shu Gan Huo Xue Tang
Jia Wei Jiao Ai Si Wu Tang
Shu Jin Huo Xue Pian
Shu Zao Yin Zi
Su Zi Jiang Qi Wan
Tai Shan Pan Shi San
Tang Shen Yi Tang
Tian Ma Jiao Nang
Tian Ma Wan
Wan Dai Tang
Wei Chang Fu Yuan Tang
Wei Tong San
Wen Fei Hua Yin Tang
Wen Jing Huo Xue Tang




Xi Xian Gou Ji Xian Lin Pi 
Tang
Xiao Ji Yin Zi
Xiao Jin Dan
Xiao Yan Shen Ji He Ji
Xin Jia Huang Long Tang
Xin Shuai He Ji
Yi Qi Chu Tan Fang
Yin Jun Hu She Tang
Yin Qiao San
Zhen Ren Yang Zang Tang
Zhi Chuang Xun Xi Fang
Zhi Dai Fang
Zhou Che Wan
Zhu Huang Bei Mu Tang
Zhuang Yao Jian Shen Wan
Testing Set
Ba Zhen Tang
Bu Zhong Yi Qi Tang
Cai Hu Yu Jin Pai Shi Tang
Chen Xiang Hua Qi Wan
Dang Gui Yang Xue Wan
Jiu Qi Nian Tong Wan
Dao Chi Wan
Fu Ke Shi Wei Pian
Hua Shuan Tong Mai Tang
Jia Jian Zhu Qi Bu Tai Tang
Jia Wei Yin Qiao San
Jian Nao Bu Shen Wan
Long Dan Xie Gan Tang
Long Dan Xie Gan Wan
Ren Shen Gui Pi Wan
Bai He Gu Jin Tang
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Table 13. Number of Samples in the Training and Testing sets after Calculation Using 
SVM
Training Set Testing Set




TP FN TN FP
1 74 501 10 0 498 1
2 73 251 5 3 749 0
3 80 211 10 2 786 3
4 79 267 1 4 733 0
5 84 231 10 6 768 1
6 88 290 3 2 710 0
7 94 210 14 2 790 0
Description of TP, FN, TN and FP in Chapter 3.5
The prediction accuracy of SVM in classifying TCM formulae is given in Table 14. 
The overall accuracy of SVM for classifying Group 1 was 99.8%; the sensitivity, 100%;
the specificity, 99.8%. The overall accuracy of SVM for classifying Group 2 was 
99.6%; the sensitivity, 62.5%; the specificity, 100%. The overall accuracy of SVM for 
classifying Group 3 was 99.4%; the sensitivity, 83.3%; the specificity, 99.6%. The
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overall accuracy of SVM for classifying Group 4 was 99.5%; the sensitivity, 20%; the 
specificity, 100%. The overall accuracy of SVM for classifying Group 5 was 99.1%;
the sensitivity, 62.5%; the specificity, 99.9%. The overall accuracy of SVM for
classifying Group 6 was 99.7%; the sensitivity, 60%; the specificity, 100%. The overall 
accuracy of SVM for classifying Group 7 was 99.7%; the sensitivity, 87.5%; the 
specificity, 100%.











Group 1 4 100% 99.8% 99.8%
Group 2 5 62.5% 100% 99.6%
Group 3 6 83.3% 99.6% 99.4%
Group 4 7 20% 100% 99.5
Group 5 8 62.5% 99.9% 99.1%
Group 6 9 60% 100% 99.7%
Group 7 10 87.5% 100% 99.7%
Description of Sensitivity, Specificity, Overall Accuracy, TP, FN, TN and FP in Chapter 3.5
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The high overall accuracies (>99%) may reflect the reliability of this method. At
least, it has strong ability to recognize negative samples. The specificities of all 7 
groups are bigger than 99.5%. For Group 2, 4, 6 and 7, all of the negative samples are 
recognized. Thus this SVM system appears to be capable of minimizing the probability
of incorrect selection of non-effective formulae. However, the high overall accuracies 
may not truly reflect its ability to pick up “true positive”, that is, the known effective 
formulae. In this study, the values of overall accuracies largely depend on the number 
of “true negative” samples, which is much higher than “true positive” samples. That is 
the reason why, in some groups, Sensitivity is much lower than Specificity and Q. In 
other words, we can say that recognition ability of “true positive” is different in
different groups, or, more seriously, the evaluation of a known effective formula may 
be incorrect. Table 14 shows satisfactory results for Group 1, Group 3 and Group 7
(sensitivity > 83%). These groups have a common character, that is, in the testing set, 
the positive samples (TP and FN) are relatively more than, at least not less than those 
samples in the other groups. In Group 1, Group 3 and Group 7, the positive sample is 
10, 12 and 16, respectively. While in Group 4, the recognition ability is particularly low, 
with only 20% of the formulae correctly classified. The number of the positive testing 
samples in this group is 5. Similarly, in Group 6, the number of the positive testing 
formulae is also 5. For this group, the sensitivity is 60%. Considering the small number 
of these positive testing samples, the results in these groups may be not reliable. 
Several factors that limit this method are given in the next paragraphs. 
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Several factors may affect the prediction accuracy. Firstly, the number of positive 
samples is critical to the predicted results. As shown in Table 14, the lower values of 
sensitivity than those of specificities may be the consequence of lack of positive data. 
Secondly, the number of negative samples also needs careful consideration. This
number should be higher than, but not much higher than the minimum. In this study, 
the number of the negative testing samples is too high, while that of the positive testing 
samples is too low. Further studies should be carried out to reduce the number of the 
former and to find more positive samples for testing. Moreover, SVM prediction can 
be further improved by choosing better SVM optimization procedure and feature
vector. The selection of feature vector may be more important. This includes the
selection of the value of each element and the construction rule of formulae’s feature 
vector from herb’ feature vector. Changing to a proper value of an element may
generate reasonable results. For example, when a herb is extremely cold, the element 
that represents “cold” is assigned a value 1.2 (Table 4). This value can be changed to 
1.1, 1.2 or whatever, and then a new feature vector is generated. Based on a set of these 
new feature vectors, an optimal training result may be achieved. This will be carried 
out in the future study. There may be a number of possible methods to construct the 
feature vector of the formulae from the herb’s feature vector. In this study, I select a 
simple one (see Chapter 3.4). This method has an obvious disadvantage, that is, it can 
only train the formulae that contain the same number of herbs. Hence, I have to
separate the formulae into several groups and then train and test them respectively. The 




Table 15. False Predicted Negative Formulae (or Potential Formulae)
Herb
Number
Formula Name Herbal Components Description
4 Negative Formula-4 443 Mu Xiang, Chuan Xin Lian 
Ye, Zhi Ma Qian Zi, Shuan 
Hua
FP
6 Negative Formula-6 18 Man Jin Zi, Ji Nei Jin, Deng 
Xin Cao, Duan Long Gu,
Man Jin Ye, Xi He Liu
FP
6 Negative Formula-6 414 Fa Ban Xia, Cang Zhu, Guo 
Lu Huang, Zhi Cao, Meng
Shi, Zi Bei Chi
FP
6 Negative Formula-6 481 Chui Pen Cao, Ye Ming
Sha,Ya Tuo Cao, Jiu Da
Huang, Ting Li Zi, Shan
Zha
FP
8 Negative Formula-8 533 Zhi Jun Tan, Xiao Gan
Cao,Gan Song, Su Geng, Su 
He Xiang You, Rou Cong
Rong, Tu Ku Shen, A Wei 
FP
Table 15 gives the ineffective formulae that are incorrectly predicted as effective 
formulae. One possible reason for the incorrect prediction is the inherent deficiency of 
this method as described above. But we cannot rule out the possibility that these
randomly generated formulae do have effective in treatment of some kinds of diseases. 
In conclusion, our study suggests the capability of SVM in recognizing
non-effective formulae and it may provide some helpful hints for herbalist doctors to 
determine the effectiveness of a TCM formula. In addition, the computation provides 
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several potentially effective formulae from the hundreds of randomly mixed formulae. 
These formulae never appear in previous literature and their effects have never been 
studied before. It is unclear whether these formulae have the therapeutic value. The 
method is expected to facilitate the prescription of new and novel TCM formulae as 




Chapter 4:  Exploration of the molecular mechanism 
of a Medicinal Herb Serenoa repens by
INVDOCK
4.1    Introduction
The pharmacological use of phytotherapeutic agents in the treatment of benign
prostatic hyperplasia (BPH) and associated lower urinary tract symptoms (LUTS) has 
been growing steadily [45-49,94-96]. The most widely used phytotherapeutic agent is 
the extract of Serenoa repens, one kind of dwarf palm plants [45-49,97-104]. Many 
clinical trials have been carried out to evaluate the effect of the extract of this herb 
[98,102,103,104,105]. A recent meta-analysis of published clinical trial data of
Permixon, one commercial product of the extract of Serenoa repens, (11 randomized 
clinical trials and 2 open label trials) [100], involving 2859 patients, reveals that in 
men with symptomatic BPH, the extract yields a significant improvement in peak flow 
rate and reduction in nocturia compared with placebo. Studies in hormone-treated
castrated rats also show inhibition effects on the increase of prostate wet weight by the 
extract of Serenoa repens [107]. When compared with commonly used drugs, an
alpha-blocker (Tamsulosin) [98] or 5 alpha-reductase inhibitor (Finasteride) [108], the 
extract shows nearly the same effects, causing parallel and statistically significant
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decreases in symptom scores and increases in maximal flow rates. These results
indicate the effects of the extracts of Serenoa repens on men with symptomatic BPH.
Its main mechanism of action is still unclear; however, possible activities have 
been demonstrated by several in vivo and in vitro studies, including antiandrogenic, 
antiproliferative and anti- inflammatory activities [96]. 5alpha-reductase catalyzes the 
reduction of testosterone into dihydrotestosterone (DHT), which is critical in
regulating prostate cell growth. Studies demonstrate that the lipido-sterol extract of 
Serenoa repens (LSESr) markedly inhibit 5alpha-reductase [109-111]. In addition, it 
also exerts an anti-androgenic effect through inhibition of the receptor binding of 
androgens [111].
In one study, LSESr significantly inhibits proliferation and induces cell death in 
both epithelium and stroma of BPH issue [112]. It also appears to affect the
b-FGF-induced proliferate of prostate cells [113] and decreases the amount of EGF in 
BPH [105]. Another study demonstrates that Serenoa repens may block PRL-induced
prostate growth by inhibiting several steps of PRL receptor signal transductions [104].
It exerts an anti- inflammatory effect through the inhibition of the enzyme responsible
for prostaglandin and leukotriene synthesis, such as cyclooxygenase and lopoxygenase 
[105].
The mechanism of this herb is unknown. It is also unclear which of the compounds 
in the extract of this herb account for its therapeutic effects. Many experiments assume 
that the lipid and sterol in this herb account for the therapeutic effects
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[101,103,104,107,109,112-117]. Shimada et al separates two compounds from the
extract: 1-monolaurin and 1-monomyristin, and finds that they show moderate
biological activities in the brine shrimp lethality test and against renal (A-498) and 
pancreatic (PACA-2) human tumor cells [118]. A number of compounds have been
extracted from this herb. To explore the mechanisms and pharmacology of this herb, 
these ingredients need to be examined first. And it is more important to explore how 
they can collectively interact with various proteins and other molecules in the human 
body. But such an investigation is hindered by the high cost and time spent on
synthesis and bioassay of natural products. Therefore alternative methods are needed 
to understand and analyze molecular mechanism of active ingredients at a higher speed 
and lower cost.
As one of the strategies for mechanistic study of natural products, the software 
INVDOCK is developed to calculate the binding between the compounds and the 
protein targets [119]. To evaluate the capability of INVDOCK in identification of
potential therapeutic and toxicity protein targets of compounds, Chen et al has tested 
on a more diverse set of compounds [42,120]. The predicted potential therapeutic and 
toxicity protein targets for a number of clinical drugs were found to be in fair
agreement with available experimental data. Knowledge of these potential targets
combined with that of proteomics and pharmacokinetic profile can facilitate the
assessment of therapeutic and toxic effects as well as the molecular mechanism of 
predicted effects. 
When this work was done, I did not have the 3D structure of 5 alpha-reductase and 
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androgen receptor, so I did not evaluate the effects of the compounds on these two 
targets. In this work, I focus on the mechanism of this herb involved in other processes 
to provide the experimentalists the most possible targets, which, I believe, will
facilitate them in the construction of experiments. 23 active compounds from this herb 
are selected to search for their potential targets through INVDOCK. Because these 
compounds are the main ingredients of Serenoa repens, the collective effects of them 
may account for parts of the actions of this herb in the treatment of BPH. 
4.2    INVDOCK Method
4.2.1  Protein Cavity Database
According to Kuntz’ s work [121], a cavity is modeled by a group of overlapping 
spheres that fill up that cavity. Each cavity entry is derived from the corresponding 
PDB entry by the following procedure: Ligands and water in a PDB protein structure 
are first removed. The surface of this protein, as defined by Richards [122], is then 
generated. The van der Waals surface of a solvent-accessible atom is generated with 
the respective parameter from the AMBER force field [123]. The inward-facing
surface covering the interface of van der Waals surfaces is computed with a probe 
sphere 1.4 Å in radius. The whole protein surface is then coated and filled with a 
cluster of spheres by a method similar to that of Kuntz et al. Each sphere is checked for 
the extent of its surrounding space covered by protein atoms. The surrounding space is 
defined as a region within 15 Å of the center of the sphere. A sphere is considered 
covered if more than 50% of the direction around the sphere is covered by protein 
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atoms. The covered spheres are then divided into separate cavity groups on the basis of 
the spatial separation of nearest neighboring spheres.
In addition, non-covered spheres close to a covered sphere in a group are included 
in that group. This is to ensure that a cavity model sufficiently covers the cavity
surface region where a tail of a ligand might be located. In some ligand-protein PDB 
structures, such as HIV-1 protease complex with its inhibitor, one or both ends of the 
ligand are found to be located in such a region. The computer-generated model
includes both the cavity and the groove to which it is connected. Because a groove 
may also be a binding site, no attempt has been made to remove grooves from a cavity 
model. A visual inspection of these and a large number of othe r proteins showed that 
all the cavities and their adjacent grooves were reasonably represented. 
3D structures of proteins from different species have been deposited in the PDB. 
Because of species-related variation in protein sequences, ligand binding is often
specific to a protein of a particular species, or a species class, and those of close 
phylogenetic distance. In general, the main interest of target identification is to
understand the molecular mechanism of the therapeutic and physiological effect of a 
ligand with respect to one species or a few particular species. Therefore, cavity entries 
can be divided into classes defined by disease-related species, sequence similarity, and 
phylogenetic distance to a particular species or species class such as human and
mammal. Additional information such as the known ligand-binding region and the 
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extent of each sphere being buried inside a cavity is also included in a cavity entry to 
facilitate the prioritized docking strategy described next.
4.2.2  Inverse-docking Procedure
The inverse-docking procedure INVDOCK is designed for the automated search of 
every entry of the protein cavity database for potential protein targets of a small
molecule. Because of the large number of cavity entries, across-the-board specification
of possible binding sites within each cavity is difficult. Hence, all parts of each cavity 
are subject to docking. Docking to sites inside each cavity starts from known
ligand-binding sites, followed by more interior sections and then the remaining part.
To save central processing unit (CPU) time, the program proceeds to the next protein 
entry when the first successful dock is obtained without an exhaustive search for the 
optimum binding mode within each cavity. Although the optimum binding mode is no t
specifically sorted, the prioritized search strategy seems to dock a ligand to a site 
reasonably close to the experimentally observed positions in most of the ligand-protein
structures studied. All cavity entries are subject to searching unless the related protein 
has been identified as a potential target.
Flexible ligand docking is similar to the multistep strategy approach proposed by 
Wang et al [124] Ligand conformation is sampled at a resolution similar to that of
Wang et al. The docking of a particular conformer to a cavity is as follows: First, the 
ligand is aligned within the selected site by the position of each ligand atom being 
matched with the center of the spheres. Because of the relatively low-resolution nature 
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of ligand conformation sampling, a certain degree of structural clash is allowed at this 
stage. A molecular-mechanics conformation optimization is then conducted by a
limited torsion space sampling of rotatable bonds in the ligand and those in the
side-chain of the receptor amino acid residues at the binding site. Each rotatable bond 
is sampled at ±15°. This is followed by 50 iterations of Cartesian coordinate energy 
minimization on all ligand and protein atoms at the binding site to further optimize the 
ligand-protein complex. Energy minimization is by a steepest decent method.
In both torsion optimization and energy minimization, AMBER force fields [123]
are used for covalent-bond, bond-angle, torsion, and nonbonded van der Waals and 
electrostatic interactions. A large number of crystal structures in PDB contain only 
non-hydrogen atoms. To save computing time and avoid the difficulty in modeling 
hydrogens, the Morse potential [125], which is a function of the donor-acceptor
distance, is used to represent hydrogen-bond terms. This potential has been shown to 
give a reasonable description of hydrogen-bond energy and dynamics in biomolecules
[126,127]. The published Morse potential parameters [126,127] are used in this work.
Protein flexibility is known to influence ligand binding, and thus methods such as 
side-chain conformational sampling and protein ensemble generation have been
explored in docking studies [128,129]. Limited side-chain conformation sampling is 
considered in INVDOCK along with additional energy minimization for all atoms at 
the binding site. However, no attempt is made to explicitly sample the ensemble of 
protein conformations. A substantial number of proteins in PDB have multiple entries 
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submitted by different groups; some of them are associated with different binding 
ligands or different mutants. Moreover, there are multiple conformations in most NMR 
structures. To a certain extent, INVDOCK searching of these multiple forms of
structures/conformations may serve as a partial sampling of the conformation for some 
proteins.
4.2.3  Scoring
The scoring of docked structures is based on a ligand-protein interaction energy 
function, ?ELP, composed of the same hydrogen-bond and nonbonded terms as those 
used for structure optimization. An analysis of a large number of PDB ligand-protein
complexes shows that the computed ?ELP is generally less than ?ET hreshold = -αN
kcal/mol, where N is the number of ligand atoms and α is a constant (∼1.0). The exact 
value of α can be determined by the fitting of the linear equation ?EThreshold = -αN to 
the computed ?ELP for a large set of PDB structures. This statistically derived energy 
value can be used empirically as a threshold for screening likely binders. A polynomial 
form of ?EThreshold involving more parameters may also be introduced to derive an
energy threshold. ?ELP can be required to be less than ?EThreshold when successfully 
docked structures are selected.
Ligand binding is competitive in nature. A drug is less likely to be effective if it 
binds to its receptor noncompetitively against natural ligands and, to some extent, 
other drugs that bind to the same receptor site. This binding competitiveness may be 
partially taken into consideration for cavities known to be ligand-bound in at least one 
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PDB entry. Ligands in PDB structures are known binders. Therefore, PDB ligands 
bound to the same receptor site as that of a docked molecule may thus be considered 
competitors of that molecule. In INVDOCK selection of a potential protein target, the 
computed ?ELP is not only evaluated against ?EThreshold but also compared to the 
ligand-protein interaction energy of the corresponding PDB ligands that bind in the 
same cavity in this or other relevant PDB entries. The ligand-protein interaction energy 
for the relevant PDB structures is computed by the same energy functions as that for 
the docked molecule. In addition to the condition that it be lower than ?Ethreshold, ?ELP
of a docked molecule is required to be lower than a competitor energy threshold
?ECompetitor when a potential target is selected. ?ECompetitor can be taken as the highest 
ligand-protein interaction energy of the corresponding PDB ligands multiplied by a 
factor β . For finding weak binders as well as strong binders, a factor β≤1 is introduced 
to scale the ligand-protein interaction energy of PDB ligands. This is because a weak 
binder may have a slightly higher interaction energy than that of a PDB binder. We 
have not found experimental data to determine the value of β . Here, β is tentatively 
determined by an analysis of the computed energy for a number of compounds. Our 
study suggests that a value of 0.8 for β leads to reasonable results statistically.
4.2.4  Selection of Compounds and Therapeutic and Toxicity Proteins
23 ingredients of Serenoa repens (Table 16) are collected according to published 
literature and books [96,130-132]. The 3D structures of these ingredients are generated 
through the following steps. First, the 2D structures are got from the Combined
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Compound Database (CCD) (http://www.chemnetbase.com). Second, these structures 
are converted to 3D structures through the software Weblab. The structures are given 
in Figures 11 to 14. 
Therapeutically targeted proteins are well documented in pharmacology literature 
and in a number of publications. A database of therapeutic targets, TTD
(http://xin.cz3.nus.edu.sg/group/TTD), has been developed [133]. TTD currently
contains 433 protein entries that have been reported to be the target of either clinical 
drugs or investigating drugs. 
Table 16. Herbal ingredients of Serenoa repens
Compound Class Compound Name
Fatty acid
(8)
Capric acid, Caproic acid
Caprylic acid, Lauric acid
Myristic acid, Oleic acid
















Figure 11. 3D Structure of Phytosterols of Serenoa repens
A: Beta-sitosterol, B: Cycloartenol C: Lupenone, D: Lupeol, E: Stigmasterol




Figure 13. 3D Structure of Fatty acids of Serenoa repens
A: Caproic acid, B: Caprylic acid, C: Capric acid, D: Lauric acid, E: Myristic acid, F: 
Oleic acid, G: Palmitic acid, H: Stearic acid
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Figure 14. 3D Structure of Ethyl Esters of Fatty acids of Serenoa repens
A: Ethyl caproate, B: Ethyl caprylate, C: Ethyl cappate, D: Ethyl laurate, E: Ethyl
myristate, F: Ethyl oleate, G: Ethyl palmitate, H: Ethyl stearate
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4.3    Results
All the 23 ingredients, including eight fatty acids, eight ethyl esters of these fatty 
acids, five sterols and two monoacylglycerides, are used to scan the protein library to 
identify their potential targets. Based on the information, their contribution to the
therapeutic and toxic effects of Serenoa repens is evaluated (Table 16). These
compounds constitute more than 85% of all the ingredients in the extract of Serenoa
repens, which is used for treatment of BPH and is believed to contain the
pharmacologically active components. Although their mechanism of action is still
unclear, theoretically, the therapeutic effects of this herb may be due to some of these 
compounds.
From the computational results, each compound can bind to several protein targets, 
ranging from one to seven. Taking into account of the overlap of the same targets by 
different compounds, finally, 25 protein targets are obtained (Table 17 and Table 18), 
each of which can be bound by seve ral different compounds. To a given protein target, 
the binding energy of different compounds varies significantly. For example, the
results show that 20 compounds can bind to prostaglandin H2 synthase (the data is not 
included in the thesis), but their binding energy is very different. The highest one is 
that of stigmasterol and the lowest one is that of capric acid. The energy is 47.6 
kcal/mol (Table 17) and 28.4 kcal/mol (this data does not include in the thesis),
respectively. Compared with the former, the latter is a very weak binder and may have 
little contribution to the interaction with the target protein. Hence, in this study, I only 
consider the interactions with sufficiently strong binding energy. When the binding 
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energy of a compound to a given protein is 3 kcal/mol less than the maximum, the 
interaction between the compound and the protein is neglected. The compounds that 
can bind to the targets are given in Table 17 and Table 18.
The action of the herbal extract has been suggested to be through the following 
mechanism [45,49,100,134]: anti- inflammatory, direct inhibition of prostate growth
and inhibition of growth factor- induced growth, anti-androgenic and anti-estrogenic
effects. A number of proteins involved in these processes are in the list of our predicted 
targets.
4.3.1  Anti-inflammatory Effects
The anti- inflammatory effects are mainly through interference with prostaglandin 
synthesis [45,100,103]. One critical enzyme involved in this process, Prostaglandin H2
synthase, is found highly expressed in prostate cancer and BPH issue, suggesting an 
important role in the pathogenesis of BPH. Studies find its expression can be decreased 
by the extract of Serenoa repens [135]. One study suggests phytosterols to be the most 
importance of inhibition of this enzyme [104]. From our study data, two phytosterols 
(stigmasterol and cycloartenol) can bind to this enzyme. On the other hand,
beta-sitosterol, believed to be the most important ingredient, is found not to bind to this 
enzyme. Further study need to be carried out to compare their effects.
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Table 17. Predicted Proteins related with BPH. [energy >= (Max-3) kcal/mol]
PDB
ID

















[137] Lauric acid -36.0
Monomyristin -34.2
Capric acid -33.7
1exz Stem Cell Factor GF-induced cell
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synthesis and cell 
growth
[142] Palmitic acid -38.3
Monolaurin -37.7
Caprylic acid -37.5










[146] Oleic acid -37.4
Lauric acid -36.8
















4.3.2  Anti-proliferate Effects
In BPH, bFGF concentration is 2 to 3-fold higher than in normal prostate.
Moreover, over-expression of FGFR1 is observed in BPH [136-138]. Studies also 
demonstrate that the extract of this herb can alter bFGF growth factors- induced growth 
and proliferation [113]. In their study, it is mentioned that lupenone and the
unsaponified fraction of the LSESr markedly inhibit the b-FGF-induced cell
proliferation. The inhibition effect may be through reducing the available growth factor 
receptor and growth factor. Our data show that one sterol (stigmasterol) can bind to 
fibroblast growth factor receptor. Moreover, fibroblast growth factor (FGF) can be 
bound by two fatty acid (lauric acid and capric acid) and monomyristin.
Another growth factor, stem cell factor, which is supposed to exert a broad range of 
biological activities during organogenesis and normal cell development [139], is
expressed in Prostate carcinoma cell lines: DU-145 and PC-3 lines [140]. Out data 
show it is bound by stearic acid. 
Besides the inhibition of the growth factor-induced growth of prostate cell,
inhibition of other proteins that are critical to the growth of cells may account for the 
effect of this herb. Ornithine decarboxylase (ODC) is essential for polyamine synthesis 
and cell growth. Polyamine is believed to participate in cellular proliferation and
differentiation. It has been found that not only the expression level of ODC mRNA, 
but also the activity of this enzyme is higher in BPH tissue than that of normal prostate 
tissues [141]. Our data show that three fatty acids, stearic acid, oleic acid and myristic
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acid can bind to this enzyme. Another rate- limiting enzyme of the polyamine pathway,
S-adenosylmethionine decarboxylase, is also in the list of predicted targets, binding by 
palmitic acid, caprylic acid and monolaurin. Both of them are found to be useful 
targets in the treatment of prostate cancer [142]. Protein kinase C (PKC) is involved in 
the proliferative response of human cultured prostatic stromal cells [143]. Our data 
show that betasitosterol, monolaurin, oleic acid and stearic acid can bind to this
enzyme.
One predicted protein target is nitric oxide synthase. This enzyme catalyzes the 
production of NO, which is involved in several important pathways. One study finds 
that inducible nitric oxide synthase is expressed in the prostate of all benign prostatic 
hyperplasia (BPH) patients, suggesting the role of NO in the pathogenesis of BPH
[144]. Monolaurin and two sterols (lupeol and stigmasterol) can bind to this enzyme. 
Vitamin A (retinol) and its derivatives, the retinoids, have been implicated as
chemopreventive and differentiating agents in a variety of cancers, including that of 
the prostate. Very little is known about the physiological role of retinoids in the
prostate. Another study finds that the nuclear retinoic acid receptors are expressed in 
BPH samples [145].  Inhibition of this receptor may neutralize the proliferate effect 
caused by retinal. Two fatty acids (oleic acid and Caprylic acid) and one sterol
(stigmasterol) can bind to this receptor.
4.3.3  Anti-androgenic and Anti-estrogenic Effects
Many studies suggest the anti-androgenic and anti-estrogenic effects of Serenoa
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repens in the treatment of BPH. L-3-hydroxyacyl-CoA dehydrogenase (SCHAD) has 
been demonstrated to convert 5alpha-androstane-3alpha, 17beta-diol (3alpha-adiol) to 
dihydrotestosterone (DHT) [146]. Dihydrotestosterone (DHT) is the major androgen 
implicated in the pathogenesis of BPH. A number of studies have shown that the 
Serenoa repens extract takes effect through reducing the generation of DHT [109-111].
It is believed that part of the anti-androgenic effects of this herb is due to the inhibition
of SCHAD. Our data show that two fatty acids (oleic acid and lauric acid) can bind to 
this enzyme. 
In regard to the anti-estrogenic effects of Serenoa repens, it has been found that it 
can competitively block the translocation of cytosolic estrogen receptors to the nucleus. 
[96,106]. Two sterols (stigmasterol and betasitosterol) can bind to this receptor. One in
vivo study demonstrates that beta-sitosterol is capable of producing a weak estrogenic
effect only at the lowest dose [148].
Our study suggests that effects of this herb on other targets may be involved in the 
treatment of this disease. In the list of our predicted proteins, besides the targets that 
have been mentioned previously, there are still some other targets. So, the next task of 
our study is to analyze these proteins to make clear the relationship of these proteins 
with BPH. Among these proteins, many proteins are found to be involved in cell 
proliferating, cell cycle, tumor metastasis and other process (Table 18). These proteins 
had higher expression in BPH or prostate cancer tissue. Targeting toward them can at 
least inhibit the conversion from BPH to advanced prostate diseases.
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Table 18. Other predicted important proteins. [energy >= (Max-3) kcal/mol]
PDB
ID
Protein Name Pathway or
Function
Ref. Ligand and Energy
1hcl Cyclin-Dependent
Kinase 2




1cws Cdc25 B-Type Tyrosine 
Phosphatase
Cell cycle [150,151] Caproic acid -21.2
1doa GTP-Binding Protein
(CDC42)
Cell cycle [152,153] Monolaurin -45.2





















Metastasis [158] Caprylic acid -38.8
Fibroblast Collagenase
(MMP1)
Metastasis [158] Betasitosterol -48.7
MMP-13 Metastasis [158] Stigmasterol -43.7
Adp-Ribosylation
Factor 6
Metastasis [159] Caprylic acid -24.2
Caproic acid -22.2
Chymase Metastasis [160] Monolaurin -43.4
1ext Tumor Necrosis Factor 
Receptor





4.3.4  Arrest of Cell Cycle
Abnormalities of cell division occur in the carcinogenesis, due to overexpression of
positive regulators of cyclin-dependent kinase (CDK) function. Many drugs have
developed toward CDK to induce growth arrest of the cells at G1 phase [149]. Studies
find that the extract of this herb can induce apoptosis and inhibit cell proliferation of
BPH tissues from patients [112]. In our data, four phytosterols (Beta-sitosterol,
lupenone, lupeol and cycloartenol) can bind to this enzyme. 
The other two important molecules involved in the cell cycle, Cdc25 B-Type
Tyrosine Phosphatase [150,151] and CDC42 [152,153] may be the potential targets. 
From our data, they are targets of caproic acid and monolaurin, respectively.
Alpha-catenin is important in cell adhesion in the process of proliferate. It has been 
shown that its production is elevated in prostatic carcinoma in comparison with benign 
prostatic hyperplasia and normal prostate [155]. Our data show two fatty acids (capric 
acid and caprylic acid) can bind to it. Plasminogen activator inhibitor 1 (PAI-1) is
suggested by one study to be involved in the tumor growth through the anti-apoptotic
effect in the benign human breast epithelial cell line MCF-10A [162]. Our data show 
that two phytosterols (cycloartenol and stigmasterol) can bind to this protein.
Awad AB et al [162] finds that phytosterol, especially beta-Sitosterol, inhibit cell 
growth and induce cell cycle arrest using MDA-MB-231 human breast cancer cells to 
evaluate the effects of phytosterols. Connolly JM’s study shows inhibition effects of 




Matrix metalloproteinases (MMPs) are a family of zinc endopeptidases involved in 
tissue remodeling and thus in various disease processes including tumor invasion and 
joint destruction. Correspondingly, these enzymes represent attractive targets for
inhibitor design and drug development. In our predicted list, four types of MMPs are 
found: MMP1 (Fibroblast Collagenase), MMP3, MMP8 (Neutrophil collagenase) and 
MMP13. Their concentrations are significantly higher in PCa patients with metastases 
[158]. MMP1 can be bound by beta-sitosterol, MMP3 by stigmasterol and cyc loartenol,
MMP8 by caprylic acid and MMP13 by stigmasterol. ADP-ribosylation factor 6 plays 
significant roles in coordinating the transition of epithelial cells from a stationary to a 
motile state when metastasis [159]. Caprylic acid and Caproic acid can bind to this 
protein. Chymase is first found in mast cells and seems to be involved in the
degradation of the extracelluar matrix (directly and/or by activation of matrix
metalloproteases), stimulation of submucosal gland cell secretion, and
complement-mediated inflammation. Given the variety of pathophysiological
processes in which chymase is involved, inhibitors of this enzyme may be potential 
drugs in cardiovascular and inflammatory diseases [160]. Monolaurin can bind to this 
protein. Cathepsin B is among the candidate proteinases believed to participate in 
invasion and metastasis. Cathepsin B often presents with higher amounts in malignant 
tumors than in normal tissues or benign tumors. Numerous clinical studies have
confirmed a correlation between cathepsin B expression, disease progression, and
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clinical outcome for patients with diverse types of tumors [156]. Stigmasterol and 
monomyristin can bind to this protein. Prolyl oligopeptidase activity is significant 
higher in tumours of prostate, lung and sigmoid, than in the healthy tissues. It supports
the possible involvement of prolyl oligopeptidase in the renin-angiotensin system and 
in the pathogenesis of hypertension [157]. Out data show that ethyloleate bind to it.
Some studies have demonstrated the inhibitory effects of fatty acids [165,166] and 
phytosterols [163,167,168] on metastasis of cancer cells. The effects of other
compounds, such as ethyloleate, should be investigated further. Although few
experiments have been carried out to prove the relationship between these proteins and 
the pathogenesis of BPH, our study seems to indicate that they play an important role 
in this process.
4.4    Discussion
The results show that most of these chemical ingredients of Serenoa repens can 
bind to a number of targets, which has been proven by experiments. Moreover, our 
computational results also provide additional potential protein targets of these
compounds. The results show in Table 19 that a compound can only bind to one or a 
few protein targets, which indicates the role of this herb in the treatment of BPH is due 
to a collective effect of the compounds.
The results indicate that not all compounds are helpful to the overall action of this 
herb. 5 of the 23 compounds, including ethylcappate, ethylcaproate, ethylmyristate,
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ethylpalmitate and ethylstearate, may have little contribution to the expected actions of 
this herb. These five compounds have their own target proteins. But compared with the 
other compounds, they are relatively weak binders to these targets. For example, both 
ethylstearate and stigmasterol are predicted to interact with Prostaglandin H2 Synthase,
but the latter strongly docked into the protein. Hence the effects of ethylstearate can be 
neglected.
Table 19. Summary of Compounds and their predicted targets
Compound Predicted Targets
Capric acid Fibroblast Growth Factor 1
Alpha-Catenin
Caproic acid Tumor Necrosis Factor Receptor
Adp-Ribosylation Factor 6
Cdc25 B-Type Tyrosine Phosphatase
Caprylic acid S-Adenosylmethionine Decarboxyla
Alpha-Catenin
Neutrophil Collagenase (Mmp 8)
Adp-Ribosylation Factor 6
Lauric acid Fibroblast Growth Factor 1
L-3-Hydroxyacyl Coa Dehydrogenas
Myristic acid Ornithine Decarboxylase
Oleic acid L-3-Hydroxyacyl Coa Dehydrogenas
Protein Kinase C
Ornithine Decarboxylase
Palmitic acid S-Adenosylmethionine Decarboxyla
Stearic acid Ornithine Decarboxylase
Protein Kinase C
Stem Cell Factor













Lupenone Cyclin-Dependent Kinase 2
Lupeol Nitric Oxide Synthase
Cyclin-Dependent Kinase 2






Prostaglandin H2 Synthase (Cyclooxygenase)
Estrogen Receptor
Cathepsin B
Ethylcaprylate Tumor Necrosis Factor Receptor







Monomyristin Fibroblast Growth Factor 1
Cathepsin B
Among the interaction between the predicted targets and the ingredients of Serenoa
repens that have been mentioned above, many have not been proven or implicated by 
experiments. The discrepancy arises for a number of reasons.
It is not expected that exhaustive experiments have been done to determine all 
protein targets of a given compound, nor the multiple compounds of one herb. Because 
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the protein expression, protein concentration and accessibility vary largely in different 
cell system, on which many experimental studies of compound are based, observation 
of the molecular events related to the ligand-protein interaction is also difficult. These 
targets do not exist or have lower level in these cells. Although the binding energy 
suggests that the interaction should be possible, but not exist in these cells. The
discovery of protein profiles can provide useful information to facilitate the study
using our method.
Another discrepancy is caused by the difference of absorption and distribution of
these compounds by different cells or issues. Even if a large doze of one chemical drug 
is taken, when it arrives at its protein target, its concentration may become very low 
compared with the initial concentration. On the contrary, a chemical with low initial
concentration may easily arrive at its targets to take affect efficiently. In this regards, 
when we select the compounds, we chose not only those with great amount in the 
extract but also those with little amount. Besides, to determine the potentia l ligands of 
one given protein, we take into account of the binding energy. If the binding energy of 
a compound was 3 kcal/mol less than the maximum, the binding of the compound is 
neglected. Considered that the binding ability is exponential with the binding energy, 
this selection role may reasonably pick up the correct interaction. 
The capability of the inverse docking approach in identifying potential protein 
targets of a small molecule is constrained by the relatively limited number of available 
protein 3D structures. This is particularly true for membrane-bond receptor proteins 
that are key therapeutic targets for a variety of diseases. Moreover, some of the PDB 
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structures may be of little relevance to binding study for a particular molecule. These 
include entries containing an incomplete section or a chain, protein mutants that are 
structurally different from the corresponding proteins investigated in experiments,
ligand-bound proteins whose conformation is relevant only to a specific set of
compounds and macromolecular complexes unrelated to a particular biological process 
studied experimentally. Computer selection of such irrelevant entries may thus
generate ‘false hits’. Anticipated rapid progress instructural genomics [169] is
expected to provide a more diverse set of relevant structures. Knowledge from study of 
protein functions also facilitates the selection of relevant structures in determination of 
potential protein targets related to a particular cellular or physiological condition.
In our study, 5 alpha reductase, which has been long suggested to be the most 
important target in treatment of BPH, is missed because of the lack of 3D structure. 
Experiments demonstrate that 5 alpha reductase is a very important enzyme involved 
in the proliferation of the prostate. Studies show that inhibition of this enzyme could be 
a useful method to cure diseases related with the prostate. This problem can be
partially alleviated by rapid progress in high-throughput X-ray crystallography and 




4.5    Conclusions
Our study provides the potential targets of Serenoa repens in the treatment of BPH, 
part of which have been demonstrated by previous experiments to be bound by some
compounds in the extract. Besides these interactions, other predicted bindings between 
particular compounds and protein targets have not been proven by experiments.
Moreover, from our data, other important targets may be involved in the pathogenesis 
of BPH and can be targeted by Serenoa repens. Thus further studies need to be carried 
out to evaluate these protein targets and the role of these compounds. In conclusion, as 
a relatively fast-speed and low-cost tool, this software may find application in





In this work, I develop a new TCM database to provide comprehensive information 
about all aspects of TCM including prescription formulae, constituent herbs, known 
herbal ingredients and their molecular actions. The therapeutic effects, adverse
reactions, clinical indications and applications are provided at the levels of prescription, 
individual herb and herbal ingredient respectively. Traditional terminologies about
medicinal herbs such as tastes, flavors, site of actions, toxicity level, and therapeutic 
class are also given.
The study suggests the capability of SVM in recognizing non-effective formulae. 
Almost all negative formulae are correctly classified. Especially in Group 2,4,6 and 7, 
all of the negative samples are correctly recognized. The study may also have some 
helpful hints for herbalist doctors to determine the effectiveness of a TCM formula.
Except Group 4 (formulae contain 7 herbs), the sensitivities of the other groups are 
more than 60%. Especially, this method has satisfactory performance for groups in 
which the formulae contains 4,6,10 herbs, respectively. In these groups, the
sensitivities are more than 83%. In addition, several potential effective TCM formulae
are derived from hundreds of randomly mixed recipes. These formulae never appear in 
previous literature and their effects have never been studied before. It is unclear
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whether these formulae have the therapeutic value. It is expected that the method can
be an alternative approach to study formulae while more and more formulae are under 
scientific studies.
The other part of this work is focused on the molecular mechanism study of herbal 
medicines by a computer-based method INVDOCK. In this study, I examine the 
interaction between the chemical ingredients of a medicinal herb Serenoa repens and a 
cavity database to generate the potential targets of these compounds. A total of 25 
potential targets are obtained, each of which can be bound by several different
compounds. Among the list of the targets, a number of proteins have been proven by 
experiments to be bound by the compounds. Moreover, many protein targets are found 
to be involved in cell proliferating, cell cycle, tumor metastasis and other processes
and have higher expression in BPH or prostate cancer tissue, indicating the important 
roles in the treatment of BPH. The computational results indicate the feasibility of 
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